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Abstract
The vertebrate microbiome consists of the bacteria, fungi, archaea, protozoans, and viruses that inhabit
the body at diverse locations including the skin, mouth, upper airways, urogenital tract, and digestive tract.
These microorganisms are known to synthesize vitamins, interact with and tone the immune system, and
dramatically affect human health. A long list of diseases has been associated with imbalances in
commensal microbiome communities. The work presented in this dissertation aims to characterize the
microeukaryotic and archaeal components of the gut microbiome through development of wet lab
techniques and in silico methods, and apply them to the study of response to antibiotics. These methods
provided a picture of the healthy fungal and archaeal communities in the gut, with high prevalence of the
yeast Saccharomyces and the archaeon Methanobrevibactor, along with several other species. These new
tools were then used to investigate the longitudinal changes that the microbiome undergoes when treated
with heavy antibiotics. Using an antibiotic cocktail containing ampicillin, neomycin, vancomycin, and
metronidazole in a mouse model, we found that bacterial communities were effectively suppressed and
fungi grew out by one to two orders of magnitude. After we discontinued antibiotics, bacterial and fungal
cell counts returned to baseline levels within one week, but community composition was still significantly
altered. Eight weeks after cessation of antibiotics, fungal community composition was not significantly
different from non-treated controls, but several mice continued to have elevated levels of yeasts that had
grown out during antibiotic treatment. The bacterial community composition was still significantly
different from non-treated controls. Ultimately, this work demonstrated potentially deleterious long term
effects of antibiotic use, and emphasizes how strong cage effects can be in mouse studies. The research
performed in this dissertation will aid researchers looking to study all three domains of life and take into
account the effects of commonly used antibiotics in future microbiome studies.
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ABSTRACT

DYNAMICS OF MICROEUKARYOTES AND ARCHAEA IN THE MAMMALIAN GUT
MICROBIOME
Serena Dollive
Fredrick D. Bushman
The vertebrate microbiome consists of the bacteria, fungi, archaea, protozoans, and
viruses that inhabit the body at diverse locations including the skin, mouth, upper airways,
urogenital tract, and digestive tract. These microorganisms are known to synthesize vitamins,
interact with and tone the immune system, and dramatically affect human health. A long list of
diseases has been associated with imbalances in commensal microbiome communities. The work
presented in this dissertation aims to characterize the microeukaryotic and archaeal components
of the gut microbiome through development of wet lab techniques and in silico methods, and
apply them to the study of response to antibiotics. These methods provided a picture of the
healthy fungal and archaeal communities in the gut, with high prevalence of the yeast
Saccharomyces and the archaeon Methanobrevibactor, along with several other species. These
new tools were then used to investigate the longitudinal changes that the microbiome undergoes
when treated with heavy antibiotics. Using an antibiotic cocktail containing ampicillin, neomycin,
vancomycin, and metronidazole in a mouse model, we found that bacterial communities were
effectively suppressed and fungi grew out by one to two orders of magnitude. After we
discontinued antibiotics, bacterial and fungal cell counts returned to baseline levels within one
week, but community composition was still significantly altered. Eight weeks after cessation of
antibiotics, fungal community composition was not significantly different from non-treated
controls, but several mice continued to have elevated levels of yeasts that had grown out during
vi

antibiotic treatment. The bacterial community composition was still significantly different from
non-treated controls. Ultimately, this work demonstrated potentially deleterious long term effects
of antibiotic use, and emphasizes how strong cage effects can be in mouse studies. The research
performed in this dissertation will aid researchers looking to study all three domains of life and
take into account the effects of commonly used antibiotics in future microbiome studies.
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CHAPTER 1: Introduction
History of Microbiome Studies
For over a century, microbial life has been known to live in the healthy human gut [1].
Early methods to study the microbiome were restricted to culture based methods [2] and light
microscopy [1]. These studies were extremely limited, because only a small fraction of bacteria
are culturable [3]. Standard culturing methods may not detect species that are restrictive
anaerobes or auxotrophic. Also, culture based studies are highly biased towards species with the
ability to grow quickly and thrive in the selection media used in a specific study [4]. Basic
microscopic techniques often have difficulty differentiating between species with similar size and
morphology. Advanced phylogenetic stains using Fluorescent In Situ Hybridization (FISH) are
available, but only provide visual information about a microbial community [5].
Microbial community characterization was greatly advanced by the invention of Sanger
sequencing technology in 1977 [6], which did not have the extreme biases seen in culture based
methods and enabled researchers to study a much larger proportion of a microbial population.
Early studies used clone based Sanger sequencing, which provided a larger view of microbiome
communities but was still hampered by low throughput limitations [7]. The advent of high
throughput DNA sequencing in the mid 2000s with early next generation sequencing technologies
such as 454 Pyrosequencing[8], Solexa sequencing [9], and SOLiD sequencing [10], enabled
researchers to produce a large number of reads at a much lower cost than the older Sanger method
and generated read coverages large enough to reflect the true microbial populations in diverse
microbial communities.
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Characterization of Microbiome Communities
There are several strategies used to characterize complex microbial communities. The
most popular method for simple analysis is amplicon based sequencing. Amplicon based
sequencing consists of targeted amplification of a conserved, yet polymorphic region that appears
in all members of the target clade. Ideally, the primer landing sites should be sufficiently
conserved to match the primers and amplify without bias for different species, and the genomic
DNA that lies between the primers must be sufficiently variable between related species to allow
differentiation [11]. Many different genes are used for amplicon based sequencing in different
clades. The 16S ribosomal RNA gene is used almost exclusively in bacteria [12], although other
amplicons have been proposed [13]. The 16S rRNA and rpoB genes [14] are used in archaeal
sequencing. The 18S rRNA gene, 28S rRNA gene, and Internal Transcribed Spacers (ITS 1 and
2) are often used to characterize fungi [15] and protozoa [16,17,18]. Amplicon based sequencing
allows the investigator to identify community members rigorously, but does not provide any
details about community gene content more broadly.
Shotgun metagenomic sequencing has become increasingly popular for characterizing
microbiome communities. Metagenomic sequencing of communities is performed similarly to
genome sequencing: DNA is extracted, shredded, and sequenced [19]. Once sequencing is
complete, data is assembled into contigs through traditional genome assembly methods [20] or
specialized methods, such as de Bruijn graph assembly [21] or binning with self organizing maps
[22]. Data can be analyzed to determine which genes and metabolic capabilities are present in a
community. Nevertheless, taxonomic attribution is difficult with shotgun sequencing, because
many of the genes found may not be present in available databases. Some researchers use 16S
genes mined from sequencing data to estimate the relative abundance of species [19]. Others have
proposed using many phylogenetic markers simultaneously to calculate the relative abundance of
2

species found [23]. Even with improved classification methods, a bias against the detection of
rare community members still exists. In recent years, shotgun sequencing has become
increasingly popular with increases in read length and throughput in Solexa sequencing [19],
which enables better sample coverage and more thorough community characterization.
Recently sequencing of bulk RNA (RNA-Seq) from microbiome samples has become
popular [24]. Such studies allow researchers to determine which genes are being actively
transcribed within a microbial community, which is not possible with DNA sequencing. These
studies can elucidate community dynamics and help determine which community members are
responsible for metabolic activities [25]. Despite these useful insights, RNA-Seq does offer new
bioinformatic challenges. RNAs cannot be assembled into large contigs like genomic DNA: reads
are often mapped back to reference genomes, and analysis quality is more dependent on the
number and quality of reference genomes [26].

The Gut Microbiome
The microbiome consists of the bacteria, archaea, fungi, protozoa, and viruses that live on
and in the human body. It is estimated that microbial cells outnumber human host cells by 10 to 1
[27], and the cumulative gene content is approximately 3.3 million protein coding genes [19].
Commonly studied body sites include the mouth [28], skin [29], upper airways [30], urogenital
tract [31], and digestive tract [32]. Different body sites have been documented to contain unique
communities [33], mostly attributable to differences between sites such as pH, oxygen content,
salinity, temperature, nutrients available at the site, and other factors [33,34,35,36].
The digestive tract is of particular interest, because it contains the majority of commensal
microbiome cells [19]. A majority of the host immune system cells line the digestive tract and
interact with the microbiome [37]. Furthermore many digestive diseases such as Crohn’s disease
3

[38], ulcerative colitis [39], inflammatory bowel disease [19,40], colorectal cancer [41], and
Clostridium difficile infection [42] have been associated with disruptions in the gut microbiome.
Interestingly, a wide spectrum of non-digestive diseases including diabetes [43], obesity [32],
liver diseases [41], rheumatoid arthritis [44], and autism [45] have also been associated with
changes in the microbiome as well.
Each unique section of the digestive tract has a distinct community [46,47]. pH [47], bile
salt type [27], and oxygen content [48] all vary in different digestive organs, shaping the contents
of the microbial communities. Commonly, stool samples are used to study the gut microbiome,
because they are less invasive than collection methods using an endoscope or surgery, and have
been documented as an adequate surrogate for the communities of the lower gastrointestinal tract
[49].
Most gut microbiome studies have been restricted to analyzing the bacterial communities
exclusively. This is due to the fact that the majority of microbiome cells are bacterial [50] and
robust characterization methods for bacteria have been developed [49]. Several sets of primers
targeting the bacterial 16S are widely used [51]. There is no single core bacterial community in
the gut, but more recent analysis has revealed the presence of enterotypes: sets of specific bacteria
that co-occur in individuals [52]. The initial enterotype study proposed three unique enterotypes
[52], but others have postulated the existence of only two [53]. The two accepted enterotypes are
dominated by Prevotella and Bacteroides, respectively. The more controversial third enterotype is
postulated to be dominated by Ruminococcus [52]. All three enterotypes perform core
microbiome functions including vitamin synthesis, energy regulation, and conditioning the host
immune system [54]. Regardless of the enterotype, the gut bacterial community consists primarily
of Bacteroidetes and Firmicutes [55]. Proteobacteria are common but a minority component
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[33]. Several other phyla including Actinobacteria and Fusobacteria appear at very low levels as
well [41].

Fungi
The fungi are a distinct group of micro- and macro-eukaryotes. Both fungi and animals
are members of the opisthokonts, which are characterized by a single flagellum [56] and
conserved insertions in elongation factor-1α and enolase, and supported by several single gene
phylogenies [57]. Fungi have organelles and cell metabolism similar to those in animals, and the
yeast Saccharomyces cerevisiae is often used as a model organism to study genetics and
molecular biology for insights into human biology [57]. Nevertheless, fungi contain a rigid cell
wall structure, which is not seen in animals [58]. Fungal cell walls consist of layers of mannan, βglucan, and chitin in different configurations across fungal species and are difficult to lyse with
traditional DNA extraction methods [59]. Many fungal species have variable ploidy. Many
species have haploid, diploid, and polyploid states [60] and genders or mating types within the
haploid state [61]. Also, some fungal species can be multinucleated [62,63]. Fungi have been
observed in nearly all environments with which human come into contact. They can live in soil
[64], water [65], and inside living organisms [66], and can become airborne [67].
Fungi and the Microbiome
Pathogenic fungi are a public health problem and have become increasingly so in the past
several decades with increases in susceptible populations. Specifically, patients with diseases
such as HIV/AIDS [68] and hematological cancers that weaken the immune system [69] are at
elevated risk. Similarly, patients that have had solid organ [70,71] or bone marrow transplants
[72], antibiotic exposure [73], antifungal exposure [73], received systemic corticosteroids [74], or
used a catheter [73] are also at risk. Many fungi can cause invasive fungal infections such as
Candida, Aspergillus, Cryptococcus, Histoplasma, Mucor, and Coccidioides spp., among others
5

[75,76,77]. Infections can be local and relatively minor, as seen in some cutaneous infections
[78], but many are severe and widespread as in fungal pneumonia [79] or invasive systemic
infection [80]. Fungal infections are particularly serious because they have a higher mortality
rate, over a third of cases in some studies [81,82]. Recently, epidemiologists have seen the rise of
strains of Candida [83], Aspergillus [84], and Cryptococcus spp. [85] that are resistant to
commonly used azole drugs. These isolates are a growing health concern, especially because the
populations of susceptible patients have been increasing [86].
Fungi also inhabit the human body as commensal microbes without causing disease.
Candida spp. have been found in the gut of a majority of humans with culture based methods,
and early sequencing methods indicated that more uncultured fungi are present [87]. The
majority of fungal cells on the skin are Malassezia spp., but culture based evidence suggests that
several other species inhabit the skin including Debaryomyces and Cryptococcus spp. [29].
Culture independent methods indicate that a large diversity of species occupy the oral cavity,
including Candida and Cladosporium spp. [88]. Commensal fungi usually do not cause acute
infection, but in some instances have been linked to disease severity. In patients with ulcerative
colitis, the presence of Candida has been associated with increased disease severity in specific
host genotypes [39]. Outgrowth and infection of commensal Candida commonly occurs when
non-pathogenic yeast forms grow hyphae and invade local tissue. Differences between the host
response to yeast and hyphal states are not well understood, but the host immune system
recognizes the fungal cell wall as a pathogen-associated molecular pattern (PAMP) and has
specific receptors, including Dectin-1 and Dectin-2, that detect and respond to fungi [89].

Protozoa
The Protozoa consist of a diverse paraphyletic group of single celled and multicellular
organisms spanning the domain Eukarya. Protozoa contains many high level groups, including
6

rhizaria, amoebozoa, alveolata, stramenopiles, and excavates [57]. Protozoan organisms are
highly diverse. While all protozoa contain the same basic eukaryotic cell structure, many species
have evolved specialized organelles [90,91,92]. Determination of the protozoal and the
eukaryotic phylogeny has proven difficult, and numerous arrangements of high taxonomic levels
and rootings have been proposed in recent years [57,93,94].
Protozoa and the Microbiome
Many protozoan species are human pathogens and the cause of public health problems in
developing and tropical nations [95]. Many Protozoan diseases such as leishmania [96], malaria
[97], Chagas disease [98], and African sleeping sickness [99] are blood borne pathogens that are
transferred through an insect vector and cause millions of deaths and hundreds of millions
illnesses annually [100]. Other protozoan pathogens have an oral route of infection: Giardia
[101], Entamoeba [102], Blastocystis [103], and Balantidium [104] and cause gastrointestinal
disease.
Protozoans have also been documented to live in the gut microbiome without causing
disease. Several species of amoeba [105] along with recognized pathogens like Giardia [106] and
Blastocystis [107] have been found to live commensally in the gut. Nevertheless, it is generally
believed that commensal protozoans are a minority community component. Commensal
Blastocystis and fungi far outnumber other microeukaryotes [108]. Nevertheless, further studies
are needed to understand the occurrence and role of non-fungal microeukaryotes in the gut
microbiome in health and disease.

Archaea
The archaea are a unique domain of prokaryotic life more closely related to eukaryotes
than to bacteria [109]. Even though members of the archaea were known and isolated in the
7

1930s [110], archaeal species were initially classified within bacteria [111] and were not
recognized as belonging in a clade apart from bacteria until 1977, when Carl Woese proposed that
archaea were a distinct lineage through phylogenetic analysis of 16S ribosomal (rDNA)
sequences [112]. Currently, there are two main archaeal kingdoms consisting of the majority of
known species: Euryarchaeota and Crenarchaeota [113]. Additional kingdoms have been
proposed to accommodate fringe species such as Nanoarchaeota (consisting of the species
Nanoarchaeum equitans) [114] and Korarchaeota [115,116] (consisting of Korarchaeum
cryptofilum)[117]. Recent phylogenetic analysis of sequenced archaeal genomes has led to the
proposal of a third main kingdom: Thaumarchaeota, consisting of mesophilic species formerly
classified within Crenarchaeota [118]. More deep branching archaeal kingdoms have been
proposed as recently as 2011 [119], and the taxonomic and phylogenetic structure of the archaea
and its exact relation to the Eukarya are still debated [120].
Cellular analyses of archaea have revealed that the domain has a unique cell structure and
distinct metabolic capabilities. For example, the cell wall architecture is diverse across archaeal
clades but significantly different from the bacterial cell wall [121], often difficult to lyse [122],
and believed to be widely resistant to the enzyme lysozyme [123]. Additionally, archaea have
even evolved exclusive cell wall structures such as the cannulae and hami [121], and archaeal
membranes consist of ether linked lipids instead of ester linked lipids [124]. Methanogenesis is
exclusive to the archaea and requires a complicated cascade of enzymes [125]. Similarly, several
archaeal species have been documented to use highly modified enzymatic pathways in central
glycolysis reactions [126]. The archaea are truly a separate clade from bacteria, confirmed by
structural and biochemical distinctiveness.

8

Archaeal Detection in Environmental Samples
Archaea have been found in a wide range of environments and commonly contain
specific adaptations for their environment. Several species have been found in extremely hot and
acidic environments [127,128]. These organisms have evolved heat and acid resistant enzymes
[129], long, branched, and highly saturated membrane lipids [124], and proton pumps to keep the
pH within the cell up to 5 orders of magnitude lower than the exterior environment [130].
Conversely, archaea have been found in psychrophilic environments below 0°C and are believed
to be able to survive at lower temperatures [131]. These archaea adjust to cold temperatures by
having a cell membrane consisting of less saturated lipids [124] and reducing the use of charged
amino acids [132]. Archaea have also been found in hypersaline environments such as the Dead
Sea [133] and the Great Salt Plains [134]; these archaeal species contain enzymes adapted for
activity in saline environments [135]. In addition to extreme environments, archaea are
commonly found in more mesophilic environments such as freshwater lakes [136], sea water
[137], wetlands [138], and soil [139].
Archaea in the Gut Microbiome
In addition to residing in most environmental locales, archaea have been documented to
live commensally in the microbiome. Methanobrevibacter smithii has been long considered to be
the dominant archaeon in the human gut [50,140], living in a majority of humans [122,141]. M.
smithii is believed to complete energy harvesting by absorbing CO2 produced by other microbes
and converting it to methane [142]. Furthermore, the presence of M. smithii is enriched in the
Ruminococcus-containing enterotypes [52] . Other species within the Methanobrevibacter genus
have been detected in non-human primates [143], ruminants [144], and termites [145].
Additionally, methanogens related to Methanobrevibacter have been found in primates [143],
swine [146], and cockroaches [147].
9

Archaea in the gut are much less diverse than the bacterial inhabitants. Often M. smithii is
the only archaeal species detected [140], and the M. smithii population usually exhibits limited
genetic diversity. In some cases it appears almost clonal in metagenomic assemblies [50]. Several
other archaeal species such as Methanosphaeara stadtmanae [122] and Methanomassiliicoccus
luminyensis [148] have been detected in lower percentages in humans as well.

Classification of Amplicon Based Sequencing Data
The use of amplicon based sequencing creates datasets often containing similar
sequences that need to be differentiated and binned by similarity into Operational Taxonomic
Units (OTUs). Each OTU represents a species within the sequenced microbial community [149].
From each OTU a representative sequence is chosen. A representative sequence can be chosen by
length, identity to other sequences, frequency within the OTU, or at random [150]. After a set of
representative sequences is generated over sequencing data, the representative sequences are put
through a classifier developed for the sequenced amplicon.
16S Classification
The most popular method to classify 16S bacterial and archaeal sequences is through
naïve Bayesian k-mer classifiers. k-mer classifiers work by generating every possible k-length
word in a query sequence and then comparing the frequency of each k-mer in the query to k-mer
distributions in each of the genera represented in a reference database. Each possible k-mer has its
own word specific prior based on its frequency of occurrence in the database, which is in turn
used to calculate the probability of observing a k-mer in a given genus. The probability of a query
belonging to a genus is calculated by multiplying together all the probabilities of observing each
of its k-mers in the genus. This value is computed across all genera, with a naive prior. That is, no
genus is deemed more or less likely to contain the query sequence prior to computation. The

10

genus with the highest probability is assigned to the query sequence [151]. Classifications to
lower taxonomic levels are possible, but most current implementations classify to the genus level.
Different k-mer lengths have been used in different implementations. The RDP
classifier uses 8-mers, because 8 and 9-mers had superior accuracy in initial tests compared to 6
and 7-mers, and 8-mers are more memory efficient [151]. Greengenes uses a 7-mer classifier, but
allows for classifications down to the species level [152,153]. This method has been thoroughly
vetted through “leave one out” testing of defined curated references and found to be robust [151].
Other classification methods relying on BLAST [150] and sequence placement within a reference
phylogeny [154] have also been used for 16S taxonomic attribution, but k-mer classifiers are
preferred because of their accuracy, speed, and lower susceptibility to misclassifications caused
by errors within the reference database. Several large software packages have been published
incorporating multiple classifiers and other statistical and phylogenetic tools for analysis of 16S
sequences [150,154,155].
18S and ITS Classification
Classification of commonly used eukaryotic amplicons is much more difficult than
classification of prokaryotic 16S sequences. The eukaryotic taxonomy is currently in a state of
flux. In the past decade many new genera have been proposed and rearranged, many of which
contain species found in the gut microbiome [156,157,158]. Furthermore, taxonomies have
undergone major rearrangements up to the phylum level in fungi [159,160] and up to the kingdom
level in protozoa [57,161]. Worse yet, until recently it was commonly accepted practice for a
single fungal species to have different names based on its morphology and mating state [15].
Upon recent examination, up to 16 taxonomic names have been found to belong to a single
species [162]. This redundant naming process was discontinued in 2011 [163], but many
databases still contain outdated names.
11

As in prokaryotes, ribosomal genes are utilized for amplicon based sequencing, but
unlike in prokaryotes, several different genes are commonly used. The 18S ribosomal subunit, the
eukaryotic homolog to the prokaryotic 16S rRNA gene, is popular and there are large curated 18S
databases available [164], but the 18S gene is too conserved for consistent differentiation below
the family level. Like the 18S, well curated resources exist for the 28S rRNA gene. The 28S
rRNA is more variable than the 18S gene, but the Internal Transcribed Spacers (ITS) 1 and 2
offer the best species level resolution and identification, particularly for fungi [15]. Several
groups have used k-mer classifiers for fungal 18S and 28S rRNA genes [150,165]; however
databases are still small compared to bacterial references, and the ITS1 and ITS2 genes are too
variable for k-mer classifiers. Also, phylogenetic tree insertion methods using have been used on
the 18S and 28S genes [154], but they are vulnerable to misclassified sequences in the reference
set and similarly are not feasible for the ITS1 and ITS2 genes. Subsequently, many researchers
have turned to using manually curated BLAST results to classify ITS sequences [39,88].

Antibiotics
Human use of antibiotics has a long history. Evidence of antibiotic use dates back to
antiquity when ancient Nubians, Greeks, and Chinese used antibiotic laced compounds
therapeutically [166,167,168]. More recently, antibiotics were studied in several laboratories in
the late 19th century [169] and were characterized and adapted for clinical use by Alexander
Fleming in 1929. Antibiotics were immediately hailed as a wonder drug for previously incurable
or untreatable bacterial infections [170]. Antibiotics are in use today across the globe as
treatments for a wide range of infections [171].
Antibiotic drugs work by exploiting differences in cellular structure or metabolism between
humans and an infecting pathogen. Many bactericidal antibiotics such as β-lactams [172] target
bacterial cell wall synthesis and maintenance. Others, like aminoglycosides [173] and
12

tetracyclines [174], disrupt bacterial protein synthesis. Sulfonamides specifically target folate
synthesis [175]. Like antibacterial agents, antifungal agents exploit differences in fungal and
human cellular biology. However, fungal cells are much more similar to human cells than
bacterial cells, and there are fewer workable drug targets. Azoles target lanosterol 14 αdemethylase, which is a necessary enzyme in cholesterol synthesis. Polyene antifungals create
pores in fungal cell membranes. Development of new classes of antibacterial and antifungal
agents is ongoing [176].
Side effects of antibiotics can range from relatively mild gastrointestinal dysfunction to serious
hematological, cardiac, pulmonary, hepatic, nephritic, and neurological problems[177].
Furthermore, repeated exposures to antimicrobial agents have led strains of many important
pathogens, such as Escherichia coli [178], Clostridium difficile [179], and Mycobacterium
tuberculosis [180], to become drug resistant and difficult to treat.
Ingested and intravenous antibiotics have been demonstrated to dramatically affect the
composition of the gut microbiome community [34]. Treatment for a bacterial infection or
prophylaxis does not just quash the offending pathogen. Dramatic microbiome and phenotypic
changes have been observed in mice [181] and swine [182] treated with even subclinical doses.
Further study is required in order to determine the long term effects of antibiotic use on human
gut health. Antibiotics have been proposed as a possible mechanism to treat disease related to the
gut microbiome, because they are clinically tested and proven to alter the gut community [34].
Several narrow spectrum antibiotics have been proposed as treatments for bacteria like C. difficile
in order to avoid altering surrounding flora as a means of preserving commensal bacteria and
health of the host [183].
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Motivation and Thesis Outline
The gut microbiome plays a central role in human health. However, at the start of this thesis
project there existed methods mainly focused on characterizing the bacterial gut flora. It is known
that the bacteria in the gut interact biochemically with archaea and microeukaryotes; therefore,
studying bacteria in isolation provides an incomplete view of the gut community. One of the
primary goals of this work was to pioneer methods to characterize these important communities.
In Chapter 2, I present a sample-to-analysis pipeline to sequence fungal and microeukaryotic
communities from human stool. This work analyzes the effectiveness of established primers and
novel primers, developed by Greg Peterfreund in the Bushman Laboratory, and describes a
classifier that I developed for classifying reads generated from those primers. In Chapter 3, I
introduce a method for successfully amplifying the archaeal 16S gene from stool samples, while
avoiding non-target DNA. Finally, in Chapter 4, I study the longitudinal effects of antibiotic
treatment in the gut microbiome using a mouse model. This study analyzes both the bacterial and
microeukaryotic communities during and after antibiotic treatment. Finally, Chapter 5 describes
the impact of this work and the new possibilities that it enables.
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CHAPTER 2: A Sample-to-Analysis Pipeline for Analysis of
Microeukaryotes in Human Stool
The contents of this chapter have been published in:
Dollive S, Peterfreund GL, Sherrill-Mix S, Bittinger K, Sinha R, Hoffmann C, Nabel
CS, Hill DA, Artis D, Bachman MA, Custers-Allen R, Grunberg S, Wu GD, Lewis
JD, Bushman FD. (2012). A tool kit for quantifying eukaryotic rRNA gene sequences
from human microbiome samples. Genome Biol 13: R60.

2.1 Abstract
Here we present a pipeline for analysis of deep sequencing data on single cell eukaryotes.
We designed a new 18S rRNA gene specific PCR primer set and compared a published rRNA
gene internal transcribed spacer (ITS) gene primer set. Amplicons were tested against 24
specimens from defined eukaryotes and eight well-characterized human stool samples. A
software pipeline (https://sourceforge.net/projects/brocc/) was developed for taxonomic
attribution, validated against simulated data, and tested on pyrosequence data. This study
provides a well-characterized tool kit for sequence-based enumeration of eukaryotic organisms in
human microbiome samples.

2.2 Introduction
Many microbiome studies are limited to characterizing the bacterial components, because
bacteria are the largest microbial component of the microbiome, changes in the bacterial
community have been associated with many diseases [1], and robust methods to characterize
bacteria have been vetted and standardized [2]. Nevertheless, single cell eukaryotes form an
important part of microbiome communities, but enumerating community membership and
proportions in complex mixtures remains challenging. Advances in sequencing technology and
bioinformatics have made possible several strategies. Shotgun metagenomics, in which all DNA
from a sample is sequenced, can yield data on the types of organisms and genes present in a
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mixed community. However, in many types of microbiome samples, eukaryotic microbes are a
minor component, so shotgun metagenomics can be inefficient and expensive for their
identification. Target gene sequencing can yield detailed information on community membership
efficiently, as with the 16S rRNA gene amplicons widely used for profiling bacterial
communities. However, there are no universally conserved regions in eukaryotic genomes
analogous to those in the 16S rRNA locus of bacteria that yield similarly low level classifications.
For microbiome samples from the digestive system, the potential masking effects of food DNA
provides another complication, and for many sample types host DNA can also interfere.
Many diseases are mediated by infections of single cell eukaryotes [3,4,5], including
infections of the gut [6], skin [7], urogenital tract [8], and pulmonary system [9]. In some cases
infections have been associated with alteration of the normal microbiome [10], as in oral thrush
[11] and aspergillosis [12], while others are apparently caused by invasion by a single eukaryotic
pathogen such as Mucor [12] or Giardia [13]. Thus better understanding of the dynamics of
eukaryotic components of microbiome communities will help in understanding and treating many
of these infections.
Eukaryotic rRNA genes and their associated transcribed spacers have been used as
marker genes [14,15,16,17], though target amplicons are not fully universal. In eukaryotes, the
18S, 5.8S, and 28S ribosomal subunits are encoded in a single locus separated by the first and
second internal transcribed spacers (ITS). The ITS RNAs are degraded shortly after transcription
and are not incorporated into the ribosome [18], thus ITS RNAs are less conserved than the 18S
and 28S RNAs. Previously developed eukaryotic rRNA gene amplicons can query these regions,
but most have not been designed or vetted for use specifically in human microbiome studies.
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Here we describe a pipeline based on rRNA gene amplicons for analysis of eukaryotes of
the human microbiome by deep sequencing. Sequencing 18S rRNA genes could be confounded
by the potentially more abundant rRNA gene sequences from the mammalian host or, in samples
from the gastrointestinal tract, from food. We thus designed an 18S rRNA gene amplicon that
avoids mammalian and plant sequences, and also compared a published ITS1 amplicon targeting
fungi [16]. We developed a flexible software pipeline (BROCC) for attributing sequences that
was tailored for use with the complex and sometimes inconsistent taxonomic assignments
characteristic of single cell eukaryotes. Because some fungi can be hard to lyse, we compared
four methods for lysis and DNA purification. Performance was tested over 24 DNA samples
from known eukaryotes and eight human stool samples. No single marker gene strategy can
quantify all eukaryotic sequences in a sample, but the methods described here allow
characterization of a large and well-characterized subset.

2.3 Materials and Methods
Sample Collection
Isolates of Aspergillus, Candida, Penicillium, Cryptococcus, and Dematiaceous mold
were obtained from the Clinical Microbiology Laboratory at the Hospital of the University of
Pennsylvania. Cultures were treated at 95 oC for five min to sterilize before removal from the
laboratory. The Pneumocystis, Coccidioides, Leishmania, Toxoplasma, Plasmodium,
Arabidopsis, Saccharomyces and human samples were from lab strains at the University of
Pennsylvania. The samples were bead-beaten for 1 min, heat inactivated for 5 min at 95oC and
then DNA was extracted with the Qiagen Stool DNA Kit using the manufacturer's protocol. DNA
extraction for these isolates was performed by Rebecca Custers-Allen. In subsequent studies we
have found that the Qiagen Stool Kit is not DNA free (data not shown), explaining the origin of
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some of the background sequences. The human stool samples were from healthy adults described
in [2,19].
Primer design
Greg Peterfreund designed the 18S_0067a_deg primer by screening a set of aligned
eukaryotic 18S rRNA gene sequences downloaded from the Silva database [20] and searching for
mammal-specific polymorphisms in the 5' conserved regions that flank the hypervariable regions.
Three bases at 65-67 were conserved in nearly all 18S rRNA gene but were absent in mammalian
18S rRNA genes, providing the basis for designing selective primers. The NSR399 primer was
obtained from the European Ribosomal RNA Database. The ITS amplicons were amplified with
the ITS1F/ITS2 primers as in Ghannoum et al [16].
DNA purification
DNA was purified from human stool (stored frozen at -80°C) using four different
methods as specified by the manufacturer except where noted. Approximately 220mg of stool
was used for each extraction. Human stool samples were extracted by Stephanie Grunberg.
The FastDNA extractions were done with the FastDNA kit as described by Ghannoum et
al[16], except the FastPrep Instrument was replaced by a BioSpec Mini-Beadbeater-16. The
archaeal extractions were preformed according to the methods of Dridi et al.[21]. The PowerSoil
extractions were bead beaten for 1.5 min in MoBio garnet tubes and centrifuged at 1500 rcf for 5
min. 1mL of supernatant was transferred to a PowerBead Tube and heated at 65°C for 10min and
then 95°C for 10min. We then used the manufacturer’s protocol, skipping the first sample vortex
(steps 1 and 2) and spun for 2 min instead of 1 at the spin filter loading step (step 15). The
samples that were purified with the PSP extraction method were placed in Lysing Matrix E tubes
(MP Biomedical) with 1400 μl of stool stabilizer from the PSP kit and were bead beaten in a
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Mini-BeadBeater-16 (BioSpec). Samples were then heated at 95°C for 15 minutes, placed on ice
for 1 minute, and spun down at 13400g for 1 minute. The supernatant was then transferred to the
PSP InviAdsorb tubes and the rest of the protocol for the PSP Spin Stool DNA Plus was followed
according to the manufacturer’s instructions. As controls, DNA free water was passed through
each DNA extraction procedure, amplified, and samples were sequenced even in cases where no
DNA was detectable after amplification ("water controls" Figure 2-5).
Sequence acquisition
Primers with 12 base barcodes were used for 454 FLX sequencing. DNA was initially
amplified with AccuPrime DNA polymerase and buffer 2 (Invitrogen). The PCR was carried out
with a 5 min denaturing step at 95°C, followed by 35 cycles of a 45 sec denaturing step at 95°C, a
45 sec annealing step at 56°C, and a 1.5 min extension step at 72°C. Finally, there was a 10 min
extension step at 72°C and samples were held at 4°C. The resulting amplicons were then
sequenced on a Roche 454 Junior instrument using the FLX Titanium chemistry according the
manufacturer’s instructions.
Bioinformatic analysis
Raw sequence data was denoised and analyzed using the QIIME pipeline [22]. OTUs
were formed by CD-HIT [23]at 99% convergence for the 18S rRNA gene amplicon and 95.2%
convergence for the ITS1 amplicon. The last 20 bases in reads from the 18S rRNA gene
amplicons were trimmed due to low overall quality. Homopolymer limits in the read quality
filtering were disabled for the ITS1 amplicon.
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The BROCC classifier
BROCC classifies query sequences by voting on BLAST hits scored by identity. All hits
are filtered for identity and coverage. Classifications are voted on in a bottom up fashion, starting
at the species level. Specific identity filters are specified by the user for the genus and species
level in addition to the main identity filter used for all other levels. Once a classification is made
at a given level, all the higher levels are called automatically. If a consensus is not reached at a
given level, that level and lower levels are left blank in the final classification. Genus and species
identity filters were set at 83.05% and 95.2% for the ITS1 amplicon and 96% and 99% for the
18S rRNA gene amplicon. All other levels were filtered at 80%. The minimum coverage and
generic classification filters were set at 70% for all amplicons. Classifications at the species
through family level required a 60% majority to be accepted. Classifications at the order level and
above required a 90% majority to be accepted. The BROCC program is implemented in Python
version 2.7. It queries the NCBI taxonomy and requires local installations of MySQL and
BLAST. The online BLAST user interface was used in error checking.

2.4 Results
DNA from food is detectable in fecal material
Humans consume other eukaryotes as food, so in order to design maximally useful
amplicons for the detection of eukaryotic rRNA gene sequences in gut microbiome samples, we
first investigated the survival of DNA during passage through the gut. In an early study of this
issue, plasmid DNA was fed to mice and low molecular weight DNA from pellets was found to
contain apparent plasmid-derived DNA, which was detected as smears on Southern blots [24].
Another study showed that 16S rRNA gene sequences in pellets of gnotobiotic (germ-free) mice
resembled 16S sequences in mouse food [25]. Our own evidence from shotgun metagenomic
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studies also suggested that DNA from food may be detectable in human stool [19], though this
has not been studied in detail. In a further study (data not shown), we gavaged mice with purified
bacterial plasmid DNA and showed that plasmid DNA could be detected in fecal pellets six hours
but not 60 hours after feeding using Taqman Q-PCR. Based on these observations, we sought to
identify eukaryotic rRNA gene amplicons that could detect single cell eukaryotes of the human
microbiome while selectively avoiding amplifying rRNA genes from food organisms and host.
Design of amplicons
We targeted the 18S rRNA gene (Figure 2-1A) due to its high conservation among
eukaryotes [26] and the substantial bioinformatic resources available for 18S rRNA gene analysis
[20,27]. We analyzed 18S rRNA gene sequences from the Silva database [20] and manually
scanned alignments for mammalian and plant specific polymorphisms. A primer was designed by
Greg Peterfreund and analyzed in silico for specificity by Scott Sherrill-Mix (18S_0067a_deg;
Figure 2-1B and C) that showed low edit distance (high identity) to 18S rRNA genes of Fungi,
Amoebozoa, Chromalveolates, Rhizaria, and most excavates, but showed lower identity to human
18S rRNA genes due to mismatches at the 3’ end. In addition, some though not all plants showed
relatively high edit distance to 18S_0067a_deg (Figure 2-1B and C) . It was paired with the
universal NSR399 18S rRNA gene primer, which is complementary to all eukaryotic clades [28].
The 18S rRNA gene is not sufficiently polymorphic for classification of some groups at a
low taxonomic level [17], so we also tested an ITS1 primer set, which queries a less-conserved
region and targets fungi selectively. We used a version of the ITS1F/ITS2 primer set previously
reported to show discrimination at low levels of the fungal taxonomy [16].
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All primers used for amplification also contained a DNA bar code, which consisted of 12
bases which indexed the DNA specimen studied. Sequence reads could then be separated by bar
code during bioinformatic analysis, allowing many amplicons to be sequenced in pools.
Classification of amplicon sequences using BROCC (BLAST Read and OTU Consensus
Classifier)
Classifying sequences from microeukaryotes presents special challenges in automated
assignment. 1) There are large numbers of accepted synonyms for many taxonomic groups. 2)
Databases contain an unusually high level of misclassifications. 3) Sexual and asexual forms
(anamorphs and telomorphs) of a single fungal species can be in different taxa, even up to the
family level. 4) Databases contain large numbers of environmental sequences with minimal or no
classification that nevertheless are returned as hits from database searches. For these reasons, we
designed BROCC to classify single cell eukaryotes while respecting these limitations. BROCC
also facilitates interfacing with the popular QIIME pipeline[22], which was originally developed
for use with bacterial 16S rRNA gene tags.
We chose to use a BLAST-based method, rather than a kmer-based classifier such as
RDP [29], because the high level of variation between closely related ITS sequences could result
in misplaced assignments. Phylogenetic-based methods such as ARB [27]have difficulties with
ITS sequences because of rapid divergence and common indels.
BROCC classifies amplicons using BLAST searches against large and relatively
uncurated databases. There are curated databases for several eukaryotic amplicons that can be
used for phylogenetic assignment [17,20], but large curated databases do not exist for ITS1,
which is used here. It is widely speculated that the great majority of fungi have not been studied,
motivating use of the broadest possible databases for human microbiome studies. BROCC uses
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blastn, but output from other versions of BLAST such as blastx can be substituted. Parameters
are user-adjustable. BROCC first filters input BLAST hits for sufficient coverage and identity to
the query sequence. If a query sequence has too many hits that are below the preset coverage
threshold (70% default), or BLAST did not return a hit, it is not classified, and a message is
written to the output file. BROCC then determines the identity and taxonomic hierarchy of each
high quality hit using a local user installed sql database and NCBI’s e-fetch tool.
BROCC then votes on the quality filtered BLAST hits, starting at the species level. At
each level of the taxonomy BROCC requires the taxon with the most votes to surpass a user
specified threshold for that level in order to accept it as a valid classification. If a sufficient
majority is not reached, BROCC will not make a classification for that level and iterate to the
next higher taxonomic level for another round of voting. BROCC filters are independently
configurable at the genus and species levels, and another filter can be assigned for the remaining
taxonomic levels. Here different defaults were used for ITS and 18S rRNA gene amplicons.
Species and genus defaults for ITS rRNA gene amplicons were chosen on the basis of [30], and
are 95.2% and 83.05%; 80% was used for higher taxa. For 18S rRNA gene amplicons, experience
(data not shown) indicated that 99% was suitable for species attribution, 96% for genus, and 80%
for higher levels.
BROCC also contains a user modifiable list of high level and partial assignments in its
configuration file. These assignments are ignored at lower taxonomic levels where they are
uninformative and can distort voting, but included in higher levels. For example, a sequence read
with a kingdom level assignment only is excluded up to the kingdom level, at which point the
vote is counted in the kingdom assignment. In cases where the proportion of high level and partial
assignments exceeds a given threshold (default 0.70), the query sequence is unassigned and
marked accordingly.
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BROCC output includes both files containing classifications with standardized taxonomy
(domain, kingdom, phylum, class, order, family, genus, species) and a second with the complete
NCBI taxonomy[31], which includes subtaxa, supertaxa, and unranked intermediate taxonomic
levels. The third file contains a log of the voting record, including how many votes were cast,
how many votes the winning taxon received, and how many generic classifications were ignored
for each query sequence. This file also indicates those queries that were unclassified. Both
taxonomy files are suitable for use in the QIIME pipeline (i. e. they are in the same format as the
output classifications as the QIIME assign_taxonomy.py script).
Testing BROCC performance on an in silico-constructed community of known membership
Kyle Bittinger verified performance of BROCC by testing assignments over an in silico
generated mixed community of known membership (Figure 2-2). We selected six eukaryotic
microbial organisms, and extracted sequences corresponding to our 18S and ITS rRNA gene
amplicon regions. To simulate the characteristics of pyrosequencing data, we added base
substitution errors at a rate of 1% and truncated each sequence by a length selected randomly
from an exponential distribution, such that the average trim value was 5 bases. For each strain, 32
different reads were generated, and then classified by BROCC.
For the 18S rRNA gene sequences, the majority of reads for each organism were
classified to at least the genus level for 4/6. One of the remaining two was classified at the family
level, and another was classified at only the phylum level (Rhodotorula bacarum). For
Rhodotorula, the NCBI taxonomy jumps from phylum to genus, disrupting attribution. For the
ITS amplicon, 4/6 were classified to the species level and one was classified at the genus level
(Penicillium). Dendryphion was unclassified, due to an abundance of short sequence matches in
the database that covered less than 70% of the ITS query and thereby disrupted assignment. We
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conclude from this that 1) BROCC works well for attribution even in the presence of sequence
errors and truncations, 2) the ITS amplicon yields lower level assignments than the 18S rRNA
gene amplicon for those sequences accessible with the ITS primers used, and 3) failed
assignments were mainly attributable to problems in the underlying database.

Testing the pipeline using a collection of DNAs from microeukaryotes of clinical interest
In order to test the performance of our pipeline, we tested DNA extracted from clinical
isolates of fungi and molds, as well as selected laboratory strains of model eukaryotes
(Supplementary Table 2-1). We also tested DNA from humans and Arabidopsis thaliana, which
are selectively non-targeted organisms. DNA samples were amplified with our 18S and ITS
rRNA gene primer pairs and sequenced using the 454/Roche platform. The raw sequences
(54,698 for 18S rRNA genes, 35,259 for ITS genes) were processed and denoised in the QIIME
pipeline [22]. OTUs were formed with percent identity values used for species level attribution
above. Taxa were assigned using BROCC. We scored a BROCC classification as correct if it
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returned an accepted synonym, anamorph, or teleomorph from the Mycobank database [32] or the
NCBI taxonomy database matching the known assignment (Figure 2-3A and B).
For the 18S rRNA gene amplicon, of the 23 classified samples tested, the major OTU
was annotated as the correct organism at the family level or lower for 18 specimens and at the
genus level or lower for 16 specimens (Figure 2-3A). Taxa called correctly at the genus level or
lower included Aspergillus, most Saccharomycetaceae yeasts (Candida and Saccharomyces),
Penicillium, Pneumocystis, and Toxoplasma gondii. A low number of reads were detected for
Arabidopsis thaliana despite the effort to avoid amplifying plant DNA, and these reads were also
correctly placed. Taxa called correctly to the family level included Leishmania and Candida
glabrata. Coccidioides was called correctly at the Class level. The human DNA sample yielded
only low numbers of reads, and the most abundant OTU matched Saccharomycetaceae yeasts,
consistent with the idea that only low level contaminating environmental DNA amplified from
these samples. Plasmodium did not amplify with this primer pair, consistent with the large edit
distance between the primer sequences and the rRNA gene target.
Cryptococcus neoformans classified correctly to the species level, but Cryptococcus
laurentii initially only classified correctly to the phylum level. Analysis showed this was due to a
large number of database entries for closely related sequences annotated as ‘Uncultured soil
basidiomycete’. We thus added this term to our list in BROCC of unhelpful classifications to be
excluded, after which C. laurentii was correctly classified to the Class level.
For the ITS gene amplicon, of the 23 samples tested, the major OTU was annotated as the
correct organism at the genus level or lower for 18 specimens (Figure 2-3B). Taxa called
correctly included Aspergillus, Cryptococcus, Penicillium, Pneumocystis and
Saccharomycetaceae yeasts (Candida and Saccharomyces). Human and Arabidopsis were not
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correctly called and the major OTU corresponded to a Saccharomyces yeast, consistent with low
level contamination. We also failed to correctly call the Apicomplexan samples (Plasmodium and
Toxoplasma), consistent with the presence of several mismatched basepairs in the forward primer,
and Leshmania. Again, for most of these the numbers of reads were low and corresponded to
abundant environmental Fungi which were probable contaminants.
One clinical strain was dubbed a Dematiaceous mold, which is not a taxonomic identifier.
Analysis of the 18S rRNA gene amplicon data called it only as Ascomycota, because divergent
annotation a lower levels obstructed deeper classification by BROCC. However analysis of the
ITS amplicon data called it as genus Exophalia, which fits with the clinical profile.
Most samples also showed additional low level OTUs, usually represented by less than 5
sequence reads unrelated to the correct call. In some cases these were identifiable as common
environmental Fungi that likely contaminated either the original DNA samples or reagents used
for DNA purification. Extensive amplification of extraction negative controls occasionally
yielded such OTUs (data shown below). Other low level OTUs in Figure 2-3 were not identified
and may be products of mispriming, chimera formation, or pyrosequencing error.
Figure 2-3. Analysis of DNA samples from known eukaryotes. A) 18S and B) ITS rRNA
gene amplicons. The sample tested is listed along the x-axis. The y-axis shows the level of
taxonomic placement of each OTU in each sample relative to the correct taxon indicated on
the x-axis. The numbers of sequence reads are shown by the size of the point. Thus large
circles high up on the y-axis indicated correct placement of the major taxa.
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Comparison of DNA purification methods
Choice of cell lysis and DNA extraction methods influences both the DNA yield and
proportions of taxa for bacterial 16S rRNA gene analysis [2], and the known difficulties of lysing
yeasts suggest the issue may be even more pronounced here. We thus compared four different
extraction methods for preparing samples for analysis of eukaryotic rRNA gene sequences: PSP
Spin Stool DNA Plus Kit, MoBio PowerSoil kit, FastDNA with Fungal Protocol [16], and an
archaeal specific extraction method [21]. For some, harsher lysis steps were used than in the
original protocols (see methods). Eight stool samples from healthy adults were subjected to
separate extractions with each of the four kits. The PSP kit yielded the most DNA on average for
the same weight of starting material. Output DNA from each method was then tested using both
the ITS1 and 18S rRNA gene amplicons.
Amplification products were separated by agarose gel electrophoresis and visualized by
staining with ethidium bromide (Supplementary Figure 2-1). The genomic DNA from the
FastDNA protocol produced no detectable amplification. The PSP and PowerSoil extractions
produced similar banding patterns on ethidium bromide stained agarose gels, though the PSP
extractions produced brighter bands overall. The archaeal extraction method produced sporadic
bands that were generally less bright than the PSP and PowerSoil samples. Based on these
findings, the PSP kit seems superior. The archaeal, PSP, and PowerSoil samples were then
compared after deep sequencing by the 454/Roche method.
Comparison of taxa reported with the 18S and the ITS rRNA gene amplicons for human stool
samples
We acquired 54,411 sequence reads for the 18S rRNA gene amplicon and 39,827
sequence reads for the ITS1 amplicon from the 8 stool samples (Supplementary Table 2-2). The
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sequence reads were clustered into OTUs and assigned to eukaryotic taxa using BROCC. The
relative abundance of community members was assessed by plotting OTUs ranked by abundance
versus their within sample abundance for samples extracted with the PSP method (Figure 2-4A
and B). The 18S rRNA gene amplicon yielded 93 OTUs and the ITS amplicon yielded 215 OTUs.
For both the 18S and ITS rRNA gene amplicons, a few OTUs contained most reads, and this was
more pronounced for the 18S rRNA gene amplicon data. The majority of OTUs assigned by
BROCC from both amplicons belonged to fungal phyla (62.4% in 18S and 90.5% in ITS1 rRNA
gene amplicons), mainly Ascomycota (81.0% in 18S and 57.4% in ITS1 rRNA gene amplicons)
and Basidiomycota (17.2% in 18S and 25.7% in ITS1 rRNA gene amplicons). Recovery of plant
and animal DNA from the 18S and ITS rRNA gene amplicons was suppressed effectively. Only
two OTUs in the 18S rRNA gene amplicon totaling 35 reads and 5 OTUs in the ITS amplicon
totaling 5 reads were classified as plant. No OTUs were classified as vertebrate, though in other
experiments with these primers small numbers of host and vertebrate sequences have been
detected (data not shown).
The numbers of reads returned for each OTU can be used as a surrogate for relative
abundance, though this measure must be used with caution due to unequal amplification due to
internal secondary structure, differential complementarity of target sequences and primers, and
different amplicon lengths. The proportions of sequences are shown as stacked bar graphs in
Figure 2-5 for the PSP and PowerSoil extraction methods. Yields from the Archaeal extraction
were lowest of the three, and showed multiple samples with few or no reads, and so were not
studied further. Sequence reads were detected in 6 of 8 negative controls (Figure 2-5 B and D), in
which DNA-free water was subjected to the purification, amplification and sequencing
procedures, but the read numbers were typically much lower than for the stool samples
(Supplementary Table 2-2).
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Figure 2-4. Rank-abundance plots for OTUs from stool samples. A) 18S and B) ITS rRNA
gene amplicons. The rank (relative abundance) of each OTU is shown on the x-axis, with
the most abundant on the left. The proportion contributed by that OTU is shown on the yaxis. The key in the upper right shows the color code for the different human subjects
studied.
For the 18S rRNA gene amplicon, 99.6% of fungal reads were assigned to Ascomycota,
while the rest were assigned to Basidiomycota, except for a 3 read OTU assigned to
Entomophthora. For the ITS amplicon, 83.7% of fungal reads were assigned to Ascomycota,
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9.79% were assigned to Basidiomycota, and 6.4% were only classified to the kingdom level.
Twelve reads from PowerSoil extraction of subject 1006 were assigned to Mucoromycotina.
The 18S rRNA gene amplicon also detected two gut parasites, Blastocystis and
Endolimax. These were not detected using the ITS amplicon, which is specific for Fungi. The
DNA extraction method used affected the results--Blastocystis was detected in both the PSP and
PowerSoil extractions from subject 2006 and Endolimax in the PSP extraction in subject 2006,
but not in samples extracted by other methods. It is unclear whether this divergence is due to bias
in the extraction methods or uneven distributions of organisms in stool samples.
The Saccharomycetaceae proved to be the dominant lineage in the eight stool samples for
both the 18S and ITS1 rRNA gene amplicons. Both amplicons were dominated by
Saccharomyces and Candida genera (Figure 2-5A and C). The majority of Saccharomycetaceae
reads recovered with the 18S rRNA gene amplicon were classified as Saccharomyces in all
samples. However, for the ITS1 rRNA gene amplicon, reads were classified as a mixture of
Candida and Saccharomyces. Analysis of the 18S rRNA gene sequence over the window queried
by our amplicon revealed that Saccharomyces and Candida are poorly distinguished over this
region, which was corroborated by a multilocus phylogeny over the Saccharomycetaceae family
[33].
Aside from the typical gut inhabitants, our study yielded several examples of fungal
rRNA genes potentially derived from food. In subject 1006, Agaricus bisporus, the common
button mushroom, was detected as a high count OTU using all extraction methods for the ITS1
amplicon samples. Claviceps purpurea, which grows on rye and other cereals and is a causative
agent of ergot [34], was detected as a rare OTUs in subjects 1002, 1006, and 2006. Wallemia
sebi, often found in food[35], was detected in 1002, 1006, 1009, and 2005 for multiple extraction
47

methods. The substantial amount of Saccharomyces that appeared in all subjects, may be derived
from bread, beer, or other leavened and fermented foodstuffs. Distinguishing fungal sequences
derived from food presents an ongoing challenge in gut microbiome studies.

Figure 2-5. Comparison of major eukaryotic microbes detected in human stool. Samples
were assayed with the 18S rRNA gene amplicon, the ITS1 rRNA gene amplicon, and the
shotgun genomic data in human stool. Human subjects and DNA purification methods are
as indicated on the x-axis. Taxa are shown at the Family level or as indicated. A) 18S
rRNA gene amplicon used to analyze stool samples. B) 18S rRNA gene amplicon
contamination controls. C) ITS amplicon stool samples. D) ITS rRNA gene amplicon
contamination controls. The contamination controls in B) and D) consisted of DNA-free
water passed through the full DNA purification, sequencing and analytical pipeline--6 of 8
samples yielded pyrosequence data, though with low read numbers.
Comparison of the performance of BROCC to other classifiers over the experimental data sets.
Taking advantage of these data, we next compared BROCC to two other classifiers,
MEGAN and MARTA, which were not specifically designed for use with single cell eukaryotes.
Supplementary Table 2-4 summarizes the differences among the programs. For more discussion
of the assignment problem see [36,37,38,39] and references therein.
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The three programs were first tested by comparing for the number of correct assignments
for the known samples in Figure 2-3. The number of samples with correct assignments for the
18S rRNA gene amplicon at the Genus level or lower were 17 for BROCC, 19 for MARTA, and
3 for MEGAN out of 20 possible. For the ITS amplicon, the numbers were 18 for BROCC, 11
for MARTA, and 6 for MEGAN out of 18 possible. Thus BROCC and MARTA were
comparable, with BROCC performing somewhat better for the ITS gene amplicon. MEGAN was
more conservative and made fewer low level assignments for ITS, because it was more strongly
influenced by database errors or alignments with only high level taxonomic placements.
In some comparisons, MARTA yielded more low level classifications due to accepting
single high quality matches for assignment, which can be an advantage or disadvantage
depending on the quality of the underlying database. MARTA classified Candida krusei as
Pichia fermentans in the 18S rRNA gene amplicon and Coccidioides immitis as Coccidioides
posadasii in the ITS amplicon. MARTA considered 4 database hits for C. krusei and 6 for C.
immitis, while BROCC considered 98 for C. krusei and 27 for C. immitis. In both cases BROCC
made a correct genus level assignment only and not the erroneous species level assignment. In
four cases in the ITS amplicon assignments, MARTA failed to make an assignment due to
interference from multiple aligning database sequences assigned as "unidentified" or
"uncultured", which were correctly classified to low taxonomic levels by BROCC.
We then compared the assignments for BROCC and MARTA against the human stool
samples, for which the composition is not known. MEGAN was not considered further due to
inferior performance on the known samples. We assigned each classification level a score.
Species level assignments received value 1, genus value 2, and so on up to unclassified, which
received value 9. Scores were compared between BROCC and MARTA. This showed that
BROCC consistently yielded lower level classifications (Wilcoxon signed rank test; p=0.014 for
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the 18S rRNA gene amplicon, and p=4.1x10-15 for the ITS amplicon). Inspection of the data
showed the numbers of unclassified OTUs generated by MARTA was largely responsible for the
inferior score.
BROCC also contains functionality assisting in implementation that is lacking in the
other packages (Supplemental Table 2-4). BROCC can extract useful information from partial
assignments -- for example, a database hit assigned only at the kingdom level, is not tallied during
the process of assignment at lower ranks, but considered in the case of a kingdom assignment.
BROCC reports the reason for excluding database hits in the output file. BROCC also outputs
file types that are easily integrated into the QIIME pipeline [22] for evaluation of microbial
community structure, accelerating downstream steps in a typical analysis.

2.5 Discussion
Here we present a pipeline for characterization of eukaryotic taxa in microbiome
samples. For many types of samples, single cell eukaryotes are a minority component, so that
shotgun metagenomic analysis is inefficient and expensive. Thus, despite the rapid advance of
methods, marker gene analysis remains the method of choice for many applications.
We describe experiments to characterize the performance of two primer sets querying the
eukaryotic ribosomal rRNA genes. Data from us and others shows that interfering DNA from
food or host cells must be considered in designing the amplification strategy. We thus devised an
18S rRNA gene amplicon that selectively avoids plant and animal 18S rRNA gene sequences.
We also studied a second amplicon that targets ITS sequences from Fungi, which also minimizes
contamination with plant and animal DNA but queries a narrower group of eukaryotes. The ITS
rRNA gene region studied is more diverse than the 18S rRNA gene region, allowing lower level
phylogenetic placement of some fungal groups. Both amplicons were effective in detecting
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Aspergillus, Saccharomycetaceae, Penicillium, and Pneumocystis. The 18S rRNA gene amplicon
selectively detected Leishmania and Toxoplasma. In stool, the 18S rRNA gene amplicon but not
ITS detected Blastocystis and Endolimax. The ITS amplicon selectively classified Cryptococcus
and the Dematiaceous mold. Neither primer set detected Plasmodium. Both amplicons detected
Saccharomycetaceae yeast as the major group in stool samples. In unpublished work, the ITS
amplicon has also been used to characterize bronchoalveolar lavage samples that were also typed
in clinical culture-based assays, producing nearly identical assignments (E. Charlson, R. Collman,
and F. D. B., unpublished data).
The present state of fungal taxonomy creates challenges in data analysis. Most fungi
have not yet been formally described by taxonomists [40], so many sequence reads will be from
unknown groups. Names differ for anamorphs (asexual forms) and teleomorphs (sexual
reproductive forms) of what are apparently the same species, either of which may occur in the
microbiome [41]. Consequently, several OTUs were classified with different names, but belonged
to the same holomorph (pool of anamorphs and teleomorphs). Even though they are the same
holomorph, Candida is taxonomically placed in the family Saccharomycetaceae, but Clavispora
is placed in the family Metschnikowiaceae. Efforts to improve databases by eliminating the dual
naming system and creating accurate phylogenies for fungi should help in this regard [17].
We demonstrated that DNA can survive passage through the GI tract of a mouse, albeit
inefficiently, and our rRNA gene amplicon assays of human stool did detect some OTUs that
likely came from food. For some of the fungal groups, it is difficult to know whether they are
true gut residents or transients from food. Perhaps the development of detailed databases of
eukaryotic rRNA gene sequences common in human food can assist in distinguishing true gut
residents from transients.
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Supplementary Information

Supplementary Figure 2-1. Comparison of PCR amplification reactions for DNA purified
from stool using different methods. Average DNA yields were: PSP 59.6 ng/μL, PowerSoil
30.4 ng/μL, FastDNA extraction 15.8 ng/ μL, and the Archaeal method 12.7 ng/μL. PCR
products were separated on an 0.8% agarose gel and stained with ethidium bromide. Top:
amplification products generated using the 18S primer pair. Bottom: amplification
products generated using the ITS1F-ITS2 primer pair.
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Supplementary Figure 2-2. Analysis of DNA samples from known eukaryotes using
BROCC, MARTA, and MEGAN. (a) 18S and (b) ITS rRNA gene amplicons classified by all
three classifiers. The sample tested is listed along the x-axis. Individual OTUs in each
sample are shown by the points, which are sized in proportion to their read counts. A point
is colored by the program and configuration used to classify that point. These data were
classified by BROCC using default settings, MARTA using default settings, MARTA using
a BLAST word size and voting thresholds to match the BROCC default settings, MEGAN
using default settings and the same blastn output used by BROCC, and MEGAN using an
abbreviated blastn output with a maximum of five hits per query sequence. The lowest level
of correct classification for each OTU is listed on the y-axis.

Supplementary Figure 2-3. Pseudocode of the BROCC program.
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Supplementary Figure 2-4. Flow chart of BROCC implementation.
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Primer

Amplicon

Sequence

18S_0067a_deg
NSR 399
ITS1F
ITS2

18S
18S
ITS1
ITS1

AAGCCATGCATGYCTAAGTATMA
TCTCAGGCTCCYTCTCCGG
CTTGGTCATTTAGAGGAAGTAA
GCTGCGTTCTTCATCGATGC

Supplementary Table 2-3. Oligonucleotides used in this chapter.
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CHAPTER 3: Protocol to Characterize Archaea in the Microbiome
through Sequencing
3.1 Abstract
Prior to this work, efficient methods to characterize archaeal communities in the gut
microbiome by deep sequencing were not available. Here we surveyed primers previously used
for archaeal community characterization in environmental samples to identify primers that both
exclude host DNA and detect archaea. Additionally we refined wet side DNA extraction methods
and thermocycler conditions to improve detection with successfully validated primers.
Ultimately, we present a working protocol for characterizing the archaeal community
composition in the gut microbiome.

3.2 Introduction
The archaea consist of a diverse group of prokaryotes that are phylogenetically closer to
eukaryotes than bacteria[1]. The archaea inhabit most settings on Earth including environments
with extreme heat[2], cold[3], salinity[4], and high[5] and low[6] pH, in addition to more
temperate locales[7]. The archaeal ability to live in extreme environments and phylogenetic
distinctiveness has lead to the evolution of characteristic cell wall, cell membrane, and surface
structures[8], along with metabolic capabilities that are unique to the archaea, such as
methanogenesis[9] and synthesis of distinctive lipids[10].
Due to the archaea’s genetic and biochemical distinctiveness, much interest has been
generated around detecting and characterizing archaea in the human microbiome, since archaea
would be potentially able to fill a unique niche in the microbiome community[11] [12]. Prior to
this dissertation, Methanobrevibacter smithii was acknowledged as the dominant commensal
archaeon in the gut microbiome[13,14] and present in most individuals[15]. Methanospheara
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stadtmanae has also been documented to occur in some individuals [16]. Here we develop
methods to characterize the archaeal community through sequencing.

3.3 Materials and Methods
Samples and DNA Extraction
In the preliminary studies the initial macaque stool samples were extracted with the
Qiagen Stool kit as per the manufacturer’s instructions and were described in detail previously
[17]. 4 of the samples (AM40, AV86, MIT4, and C2T64) came from SIV positive macaques.
The remaining 4 samples (DE20, C2T3, C2T10, and C4T1) came from uninfected macaques. All
the murine samples came from healthy mice. DNA from these samples was extracted with the
same method used for the macaques. 4 of the samples (11F, 12B, 13B, and 15D) were described
previously [18], and 3 (IKK2, IKK4, and IKK5) were produced for another unpublished study.
The human samples used for later study were derived from self reported healthy adults
and extracted with the PSP kit modified for difficult to lyse cell wall. The stool samples[19,20]
and their extraction[21] were described previously.
Primer Selection and Modification
We formed the initial set of tested primers through a search of the literature
[22,23,24,25]. The 958af primer was modified after a visual inspection of alignment to several
Solfulobus and related 16S sequences from the GenBank[26] database and the UCSC Genome
Browser[27]. The 17th base pair made degenerate from G to K (G or T).
Amplification Protocol
Initial test amplifications were preformed with the GreenTaq system. Reactions
contained 10μL genomic DNA diluted to 5 ng/μL, 2 μL of each primers diluted to 20 pmol/ μL,
65

4.3 μL Greentaq Mix, 5.7 μL water, .5 μL BSA (10mg/mL), and 2.5 μL Triton (1%). We used
the following thermocycles protocol: denaturing at 95°C for 5 minutes, 25 cycles of amplification
with 30 seconds for denaturing at 95°C, 30 seconds of annealing at 50°C or 55°C, and 72°C for
90 seconds. At the end of the program, there was an 8 minute extension at 72°C.
Later amplifications used the Accuprime system according the manufacturer’s
instructions. Thermocycler conditions were as follows: initial denaturing for 5 minutes at 95°C,
then 47 cycles of amplification with 30 seconds of denaturing at 95, 30 seconds of annealing at
variable temperatures, and 90 seconds of extension at 72°C. The annealing temperature started at
67°C and decreased by 1°C each cycle until it reached 55°C, where it remained for 10 cycles.
Next, it decreased to 53°C for 5 cycles, then decreased to 50°C for 20 more cycles. Afterwards
there was an 8 minute extension at 72°C.
Sequencing and Bioinformatics
Amplified DNA was cloned with the Invitrogen TOPO4 and TOPOXL cloning kits
according the manufacturer’s instructions. Samples were sequenced on an ABI 3730 DNA
analyzer. Sequences were classified the web based RDP classifier tool [28]. Classifications were
checked with NCBI’s BLAST and the RDP SeqMatch tool.

3.4 Results
Primer Selection
Several studies have used the archaeal 16S rRNA gene to characterize and analyze
archaeal communities in environmental samples from seawater[29,30], soil[31,32], and
others[33], prior to this work. Through a literature search, we collected 6 noted archaeal specific
16S rRNA primers (Table 3-1) [22,23,24] and paired each one with the universal 1378ar reverse
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primer[25], which amplifies both archaea and eukaryotes. We used this scheme to test the
specificity of individual forward primers.

Name

Sequence 5'-3'

Source

4aF
398aF
571aF
1040aF

TCCGGTTGATCCTGCCRG
CCRGGCCCTACGGGG
GCYTAAAGWRDCCGTAGC
GAGAGGWGGTGCATGGCC

Grobowski 2005
Baker 2003
Baker 2003
Baker 2003

958aF

AATTGGAKTCAACGCCGGR

Collins 2005

1204aF
1378aR

AGGTMBGYATGCCCCKAA
Baker 2003
TGTGTGCAAGGAGCAGGGAC Lepp 2004

Table 3-1. Primer sequences used in this chapter.
Primers pairs were queried against a set of extracted stool samples from healthy mice and
healthy and SIV infected macaques extracted with the Qiagen Stool Kit. Samples were initially
amplified using 25 PCR cycles at annealing temperatures of 50°C and 55°C, based on a
previously described procedure for amplifying 16S[17]. Amplifications with annealing
temperatures at 50°C generally produced brighter bands than the 55°C amplification but consisted
of nonspecific amplification, so amplifications at 55°C were considered.
In initial tests, two of the forward primers, 571af and 1204af, produced no bands and
were not considered. Two more forward primers, 398af and 1040af, produced visible bands, but
bands were determined to be off target eukaryotic host sequences upon Sanger sequencing. The
remaining forward primers, 4af and 958af, produced bands in a limited number of samples (Fig 31), which were verified with Sanger sequencing. All reads produced from macaque samples were
classified as Methanobrevibacter with the RDP classifier. All but one read produced from the
murine samples were classified as Methanobrevibacter. The remaining murine derived sequence
was classified with 79% confidence as belonging to the extremophile genus Thermogymnomonas,
which prior to this work has been observed in hot springs[34]. The murine samples only
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produced visible amplification with the 4af forward primer, and the macaque samples only
produced visible amplification with the 958af forward primer. The reason for this is unclear, since
k-nearest neighbor analysis with the RDP classifier tool made taxonomic assignments for reads
from both the macaque and mouse samples to archaeal species that have homology to both the 4af
and 958af primers.
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Assay Refinement
Upon assessment of sequencing results, we selected the 958aF/1378aR for further
development, due its small amplicon size (~450 base pairs), which was suitable for adaption for
454 sequencing. Through endpoint PCR testing of genomic DNA derived from pure culture
Sulfolobus solfataricus, we observed that the 958aF/1378aR primer pair does not produce visible
amplification on an ethidium bromide stained gel. Bioinformatic analysis of database sequences
revealed that this effect was caused by a point mutation 2 base pairs from the 3’ end of the 958aF
primer. This mutation occurs in species spanning the entire Sulfolobales order. Because we were
unsure if any members Sulfolobales reside in the gut microbiome, we decided to modify the
958aF primer by making the 17th base pair degenerate from G to K (G or T). This new primer
was renamed 958aF-deg.
Despite amplifying target archaeon sequences with the previously described methods,
some of the sequenced data from the 958aF/1378aR primer pair resulted from nonspecific
amplification. We implemented a complex touchdown thermocycler protocol, which reduced the
presence of off target sequences (see methods). Also, after seeing an increase in amplification
performance in fungal detection assays after surveying different extraction methods[21], we used
to the PSP extraction method modified for difficult-to-lyse cells (see methods) and saw a
corresponding increase in performance in endpoint PCR, which was unsurprising because
archaeal cell walls have been documented as relatively hard to lyse [15]. Also we changed our
PCR cocktail to use Accuprime taq, which has been documented to perform well with difficultto-amplify samples (unpublished observations), and saw a dramatic increase in amplification in
endpoint PCR. With this improved extraction and amplification procedure, we were able to detect
archaea in a higher proportion of human samples. Limited sequencing was preformed with the
Sanger method on 8 human samples extracted with the PSP kit (Fig 3-2). All reads from human
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samples were attributed to Methanobrevibacter. Off target amplification of the host genome was
not observed for these samples.

Disease
Status

Healthy

Species

Human

Subject 1002

1003

1006

1009

1011

2005

2006

2011

958/1378
Confirmed by
sequencing
Band of correct size, but
not sequenced
Figure 3-2 Amplification of human stool samples over the 958aF/1378aR primer pair. All
samples were obtained from healthy adults and extracted with the PSP kit with bead
beating. Designation of the individual from which the stool sample was obtained is
indicated by the second row. Amplification results are indicated by the colors of chart
boxes. Amplifications were preformed with Accuprime and a double touchdown 47
cycle thermocycler program.

3.5 Discussion
Prior to this work, M. smithii had been documented to live in the human gut, but genomic
assays for detection of archaea more broadly in the human microbiome were not developed. This
work demonstrates the wide spread existence of archaea in the gut and lays a foundation for
characterization of the archaeal microbiome community. While Methanobrevibactor was the
predominant species detected through sequencing, Thermogymnomonas was detected as well,
suggesting multiple archaeal species inhabit the gut. The method described here was further
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developed for 454 sequencing by Christian Hoffmann and was successfully applied to a large set
of human stool samples, where several divergent lineages were detected, including
Methanobrevibactor, Nitrosospheara, Methanospheara, Thermoplasmata, and
Thermogymnomonas. While the archaea compose a minority component of the microbiome,
further studies are needed to determine how their unique metabolic capabilities change
community function and dynamics.
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CHAPTER 4: Perturbation of Fungi and Bacteria through Antibiotics
in the Murine Gut
The contents of this chapter have been submitted for publication in:
Dollive S, Chen YY, Grunberg S, Bittinger K, Vandiver L, Cuff C, Lewis JD, Wu GD,
Bushman FD. (2013). Fungi of the murine gut: episodic variation and proliferation
during antibiotic treatment.

4.1 Abstract
Antibiotic use in humans has been associated with outgrowth of fungi. Here we
investigated the gut microbiome over 76 days of antibiotic treatment and recovery using a
controlled mouse model. Mouse stool was studied a surrogate for the microbiota of the lower
gastrointestinal tract. The abundance of fungi and bacteria was measured using quantitative PCR,
and the proportional composition of the communities quantified using 454/Roche pyrosequencing
of rRNA gene tags. Bacteria dropped >3 orders of magnitude after initiating treatment, so that
the predominant 16S sequences detectable during treatment were transients derived from food.
Upon cessation of treatment, bacteria mostly returned to their previous numbers and types after 8
weeks, though communities remained detectably different from untreated controls. Fungal
communities varied substantially over time, even in the untreated controls. Separate cages within
the same treatment group showed radical differences, but mice within a cage generally behaved
similarly. Fungi increased 40-fold in abundance upon antibiotic treatment but declined back to
their original abundance after cessation of treatment. At the last time point, Candida remained
more abundant than prior to treatment. These data show that 1) gut fungal populations change
radically during normal mouse husbandry, 2) fungi grow out in the gut upon suppression of
bacterial communities with antibiotics, and 3) perturbations due to antibiotics persist long term in
both the fungal and bacterial microbiota.

76

4.2 Introduction
The gut microbiome is generally stable but can be changed through exterior perturbation.
Perturbation can be introduced through changes in diet [1], changes in the immune system [2],
presence of a pathogen [3], and use of probiotics [4] or antibiotics [5], and others factors.
Antibiotic use is perhaps the most common and dramatic source of change in the microbiome
community and is a subject of clinical interest.
The effects of antibiotic use on the human microbiome can be challenging to clarify
fully--confounding factors include complications of the underlying diseases states and
concomitant use of additional forms of therapy[6]. Despite these difficulties, outgrowth of fungi
has been repeatedly linked to antibiotic treatment at body sites including the gut[7,8], vagina[9],
mouth[10], skin[11] and others [12,13]. Fungal infection associated with antibiotic use is of
particular concern in immunocompromised states such as HIV/AIDS[14,15,16], some
cancers[13,17,18], and transplantation[19,20,21,22] [23]. Many of these conditions necessitate
the use of corticosteroids, which further predisposes the host to fungal infection[24]. Invasive
fungal infections have been increasing in recent decades[6,17], and the rise of azole-resistant
species of Candida[12,25], Aspergillus[26,27], and Cryptococcus[14,28] brings further urgency
to understanding the interaction between commensal fungi and bacteria under antibiotic
treatment.
Rodent models have been used to study the effects of antibiotics on the mammalian gut,
using culture based[29,30], metagenomic[31], and immunologic[31,32] methods. Antibiotic
treatment can predispose the host to infection by pathogens[33,34] and alter microbial
communities long term[34]. Induced exposure to Candida albicans shapes the bacterial
composition of the murine gut during antibiotic recovery[30] and can cause gastritis[35], while
Candida tropicalis has been associated with increased severity in ulcerative colitis[36].
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Phenotypic effects have been found even after treatment with subclinical doses of antibiotics [37].
In studies of the role of the vertebrate microbiome in mice, antibiotic treatment is often used to
suppress the host bacteria, but the effect of this intervention on fungi is not commonly considered
[33,38,39,40].
Here we characterize the bacterial and fungal microbiota of mice during antibiotic
treatment and subsequent recovery after cessation. We analyzed abundance using quantitative
PCR (henceforth “QPCR”), and analyzed the types present using 454/Roche pyrosequencing of
rRNA gene tags. We found that fungi indeed grew out upon antibiotic treatment. After cessation
of antibiotic treatment, fungal and bacterial communities approached their pre-antibiotic states,
but increased abundance of Candida persisted in the gut at the last time point studied eight weeks
later. To our surprise, we also found that the fungal communities changed radically over time in
both control and treated mice. For each condition, specific fungi colonized multiple mice in the
same cage, then gave way to subsequent fungal colonists over time, and different patterns were
seen in different cages.

4.3 Material and Methods
Ethics Statement
The Institutional Review Board of the University of Pennsylvania approved all IACUC protocols
(protocol #803408). The animal care facility is operated by the University Laboratory Animal
Resources, which is fully accredited by the American Association for Accreditation of Laboratory
Animal Care. Laboratory animals are maintained in accordance with the applicable portions of
the Animal Welfare Act and their guidelines prescribed in the DHHS publication, “Guide for the
Care and Use of Laboratory Animals”. Mice are euthanized using C02 inhalation. Methods for
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euthanasia are consistent with the recommendations of the Panel on Euthanasia of the American
Veterinary Medical Association.
Mouse Husbandry
Thirty C57B6 eight week old female mice were purchased from Jackson Laboratory and placed
on a standardized diet for two weeks prior to the study to stabilize their flora. Mice were housed
by treatment group with five mice per cage. Mice treated with antibiotics received ampicillin,
neomycin, vancomycin, and metronidazole in water. Water was spiked with aspartame in both the
treated groups and controls. Mice were fed AIN-76A Rodent Diet from Research Diet (D10001)
for the course of the study, which includes 15% casein lactic.
DNA Extraction
DNA was extracted from 1-2 mouse pellets per mouse per time point. Samples were
homogenized for 80 seconds on a Mini-BeadBeater-16 (BioSpec) in Lysing Matrix E tubes (MP
Biomedical). Samples were then incubated at 95°C for 15 minutes and then cooled on ice for 60
seconds. Then samples were extracted with the PSP DNA extraction kit and using a protocol
described previously[41]. Sequences of oligonucleotides used in this study are presented in
Supplementary Table 4-1.
DNA Sequencing and QPCR
Extracted DNA was quantified with the Picogreen system. Typical volumes produced, used in
the calculations in Supplementary Table 4-2, were 250 microliters. DNA was amplified using
primers annealing to the V1V2 region of the 16S bacterial gene or the ITS1 fungal rRNA gene
spacer, and amplified with AccuPrime taq with Buffer 2 (Invitrogen). Thermocycler protocols for
16S[42] and ITS and 18S[41] amplicons were described previously. PCR amplicons were
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purified with Agencourt AMPure XP beads. Sequencing was performed on a 454 Junior using
Titanium chemistry. For both 16S and ITS amplicons, DNA free water was subjected to the same
purification procedure and analyzed by 454/Roche pyrosequencing (Supplementary Figure 4-6).
A subset of samples showed recoverable sequences, but stool samples showed distinct
community composition, so conclude that environmental contamination made a minimal
contribution to the samples analyzed.
16S qPCR was performed using the Taqman method as described previously[31]. 18S
qPCR was performed with the Applied Biosystems SYBRGreen Fast chemistry. Ten μL
SYBRGreen FAST 2X master mix, 1 μL of each primer diluted to 20 pM, and 8 μL DNA were
added to each reaction. Thermocycling was performed as follows: samples were initially
denatured once for 2 minutes at 50°C then 10 minutes at 95°C. Then samples were cycled 40
times with a dissociation step at 95°C for 15 seconds and an annealing and extension step at 60°C
for 1 minute. Primer sequences for these assays can be found in Supplementary Table 4-1. All
DNA sequences generated in this study have been submitted to the Sequence Read Archive.
Bioinformatic Analysis
Bioinformatic analysis was performed with the QIIME software package[43] using default
parameters except where indicated, and using R. Fungal reads were queried against the nt
database using NCBI’s blastn tool and then classified with the BROCC classifier[41].
Eukaryotic PCoA analysis was performed using taxonomic relationship corresponding to the
NCBI Taxonomy[44]. Because de novo tree construction using the ITS1 region is not feasible
due to length variation inherent in the ITS gene[41,45,46,47], we chose to asses Unifrac distances
between eukaryotic communities using the NCBI Taxonomy to generate taxonomic trees. To
transform the taxonomy into a phylogenetic tree, all edges between taxa were assigned equal
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weight. Classifications were curated manually for parsimony. While the fungal taxonomy is
imperfect and in a state flux[48,49,50,51], we note that in practice the Unifrac metric is relatively
robust to the method used in creating phylogenetic trees[52]. Statistical significance for
treatment groups was determined using the nonparametric Mann-Whitney test in R. Permanova
tests and Procrustes analysis were performed in QIIME.

4.4 Results
Longitudinal analysis of the murine gut during antibiotic treatment
To assess the relationship between bacterial and fungal lineages during antibiotic
treatment, an antibiotic cocktail containing vancomycin, ampicillin, neomycin, and metronidazole
was given to twenty C57B6 mice in water. After 2 weeks, antibiotic treatment was stopped for ten
of the mice. These mice did not receive any antibiotics during the remaining nine weeks of the
study (“AbxShortTerm” mice). The remaining ten mice under antibiotic treatment continued to
receive antibiotics for the duration of the study (“AbxContinuous” mice). In parallel, ten control
mice received no antibiotics over the course of the study (“Control” mice). Fecal samples were
collected over one week prior to initiating the study, then at the indicated time points during the
study (Figure 4-1). Mouse husbandry and sample collection was performed by Ying-Yu Chen.
DNA was purified from stool pellets using a procedure that included bead beating and a high
temperature incubation to facilitate lysis of fungal cells[42] by Stephanie Grunberg and Serena
Dollive.
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Figure 4-1. Experimental Diagram. The time line for the 76 days of sample collection is
shown along the top, and the periods of antibiotic treatment are shown at the bottom.
Antibiotic treatment was initiated at time zero.

Analysis of the numbers of bacterial 16S and eukaryotic 18S gene copies present after antibiotic
treatment
We first investigated the changes in abundance of bacteria and fungi, using stool
specimens as a proxy for the lower intestinal microbiome. To assess changes in abundance, we
first quantified the abundance of bacterial and fungal genomes in the samples per ng of DNA
using quantitative PCR. For bacteria, a QPCR assay was used that detected the bacterial 16S
rRNA gene, and for fungi, an assay was used detecting the 18S rRNA gene. The primers for the
fungal assay were designed to suppress amplification of metazoan DNA originating from the host
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or food materials [53]. The specificity was confirmed by pyrosequencing products of
amplification with these primers (described below and Supplementary Figure 4-1).
At the start of the study, fecal pellets contained 5X105 to 106 copies of bacterial 16S
rRNA genes per ng DNA (Figure 4-2). After initiation of antibiotic treatment, this fell as low as
100 copies per ng DNA, or a drop of >3 orders of magnitude. Upon cessation of antibiotic
treatment the community recovered to its former high numbers. Thus we conclude that the
antibiotic treatment was highly effective at reducing the numbers of bacteria present in gut, as has
been seen in many studies (e. g. [34] [54] [55]), and that the community was sufficiently resilient
to return to its former size after cessation of treatment.

Figure 4-2. Longitudinal analysis of 16S rRNA gene copies per ng of stool DNA. The
groups of mice tested are shown by the color code (key at right). Error bars indicate
standard error.
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Prior to initiation of antibiotic treatment, 1-3X105 18S rRNA gene copies were detected
per ng DNA (Figure 4-3). Upon initiation of antibiotic treatment the number climbed two orders
of magnitude, ranging between 3-6X108 copies per ng DNA. Upon cessation of antibiotic
treatment, the numbers dropped back to roughly their former levels, thus displaying a favoring of
smaller community size in the absence of antibiotic pressure.
The abundance of fungi in the Control group showed an unexpected increase at day 22.
Further analysis showed that the increase was in only one of the two cages housing the control
animals, and correlated with the appearance of a new fungal lineage at high levels in all animals
in that cage (described below).

Figure 4-3. Longitudinal analysis of 18S rRNA gene copies per ng of stool DNA. The
groups of mice tested are shown by the color code (key at right). Error bars indicate
standard error. The amplicon used was designed to suppress amplification of DNA from
mouse or food materials.
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Additional information is required to relate these numbers of rRNA gene copies to the
numbers of organisms present. This issue is addressed in the next section.
Assessing the absolute abundance of bacteria and fungi
Several corrections are required to link the QPCR data to the total number of organisms
per stool pellet. One consideration is that bacterial [56,57] and fungal [58,59] genomes typically
contain multiple rRNA gene copies. From published data on complete genome sequences, we
estimated the mean number of 16S rRNA gene copies per bacteria at 5 [56], and 18S copies per
fungal genome at 100 [59], though the number for fungi is tentative due to the difficulty of
accurately sequencing tandem direct repeats and variability in copy number.
Another concern in assessing possible fungal outgrowth during antibiotic treatment is that
the total number of microbes in pellets, and thus total DNA, may go down with treatment, so that
fungi could falsely appear to proliferate only because total DNA content went down as bacterial
numbers fell. Thus we sought to correct the above assays, which were normalized to weight of
DNA, to better reflect the counts of individual organisms by putting the final analysis on a per
pellet basis. Values for inferred microbial genomes are shown in Supplementary Table 4-2, and a
few ratios of interest are presented in Supplementary Table 4-3. Average pellet weights were
16.08 mg (SD=3.329) in the presence of antibiotic (n=20) and 18.64 (SD=2.685) in the control
mice (n=19). Thus the difference in mean weight was small (14%), so we treated starting weights
as equal below, though the difference did achieve significance (p=0.0129, Mann-Whitney U test).
DNA yields differed substantially (Supplementary Table 4-2). Quantification of yields
after 15 or 76 days of antibiotic treatment showed drops of 4.7 and 5.7 fold (Supplementary Table
4-3). Thus the analysis of the numbers of microbial genomes needs to take into account the drop
in total DNA. After withdrawal of antibiotic treatment (AbxShortTerm, Day 76), the total DNA
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yield returned to within a factor of two of the starting value. Evidently bacterial DNA is the
predominant source of DNA in mouse pellets, and the community mostly returned to its former
size after cessation of antibiotic treatment.
Taking these factors into account, we find that in the absence of antibiotic treatment, a
typical stool pellet contained ~107 bacteria, and this dropped to ~102 bacteria after 15 days of
antibiotic treatment (Figure 4-4). Fungal genomes were much less abundant initially, only in the
range of 6X103 per pellet. After 15 days of treatment with antibiotics, the numbers increased to
2X105, or an increase of ~30 fold. Fungal genome numbers remained high for the period of
antibiotic treatment. Eight weeks after cessation of antibiotic treatment, counts in the
ABXShortTerm groups returned to pretreatment level. Thus changes in fungal cell abundance
were substantial, though less than suggested by the analysis in Figure 4-3, which was normalized
to the total weight of DNA, because total DNA went down with antibiotic treatment.
Microscopic inspection of stool specimens also suggested an increase in numbers of large cells,
consistent with an increase in absolute fungal numbers (data not shown).
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Figure 4-4. Diagrams of estimated A) Bacterial and B) Fungal genomes per mouse pellet.

Analysis of bacterial lineages using 454/Roche deep sequencing
To probe microbial dynamics under antibiotic therapy, we analyzed the longitudinal
DNA samples using 454/Roche pyrosequencing. DNA was purified from stool from 13 time
points (Figure 4-1). Bacterial sequences were amplified using primers matching the 16S rRNA
gene V1V2 region [42,60]. Sequencing yielded 239,867 reads, which were condensed into OTUs
at 97% similarity and taxonomy assigned using the RDP classifier[61].
Prior to antibiotic treatment, communities were dominated by the Firmicute lineage
Lachnospiraceae and the Bacteriodetes lineage Bacteroidales, along with a substantial number of
less abundant lineages (Figure 4-5; Supplementary Figure 4-2 A-I presents time points with each
mouse shown individually). After one day of antibiotic treatment, the previously dominant
lineages decreased sharply in abundance, and Lactococcus became the dominant community
member. At later times under antibiotic treatment Lactococcus was the predominant or sole
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lineage detectable. Five aliquots of sterile mouse chow were analyzed by amplification with the
V1V2 primers and 454/Roche pyrosequencing, revealing that Lactococcus 16S rRNA genes were
the predominant phylotype in chow (Supplementary Figure 4-3). We thus conclude that
Lactococcus DNA is present in sterile mouse food, and that the antibiotic treatment eliminated
the great majority of live bacteria, i. e. the 102 bacteria detected per pellet in Supplementary Table
4-2 represents an upper bound.
After antibiotic treatment was stopped for the ABXShortTerm group, major groups that
were predominant before antibiotic treatment returned to their former levels, but at different rates.
An OTU classified as Lachnospiraceae and several OTUs classified as Clostridium returned
within one week. Several other clades, including Ruminococcaceae and other Firmicutes
increased in proportion by two weeks after cessation of treatment. Bacteroidales did not fully
return until the end of the experiment at eight weeks. Enteroccocus, Escherichia, and
Paenibacillus, which were not dominant members of the communities in the Control or antibiotic
treated groups, had elevated proportions over the recovery period but decreased in relative
abundance after eight weeks off antibiotics.
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Changes in the types of bacterial lineages were paralleled by changes in the species
richness (Figure 4-6). Prior to antibiotic treatment, 54.6 (SD=6.9) phylotypes were detected after
data from each mouse was normalized to 200 reads. After 2 days of antibiotic treatment, this fell
to 7 (SD=2.0) and persisted for the remainder of the antibiotic treatment. Upon cessation of
antibiotic treatment, the community slowly returned to its former richness reaching 49.4 (SD=5.6)
lineages over 61 days, still less than the corresponding Control group which averaged 57.2
(SD=17) lineages on the same day (p=0.02 Mann-Whitney U).
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Figure 4-6. Abundance analysis of observed bacterial lineages. Each sequence set for each
animal was rarefied to 200 sequences per sample 10 times, and the number of different
OTUs assessed. Means are indicated by points, error bars indicate the range observed. The
groups studied are indicated by the key at the right.
Analysis of microeukaryotes using 454/Roche deep sequencing
To characterize microeukaryotes, we sequenced selected samples using 18S and ITS
amplicons. 18S sequences were prepared by Lee Vandivier, and ITS sequences were prepared by
Serena Dollive. To compare samples from the different treatment groups, 134,677 ITS sequences
and 26,355 18S sequences were generated, OTUs were formed, and taxonomic attribution was
preformed with BROCC [41]. The 18S amplicon is more universal than the ITS amplicon [41],
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while the ITS amplicon provides greater resolution for some fungal lineages [48], so both were
used [53]. To check that the two amplicons were yielding consistent information, we compared
sequence samples from 15 mice amplified using both amplicons. Sequence samples were
characterized by generating pairwise UniFrac distances, then the distance matrices for each were
compared using Procrustes analysis. This showed high correlation between the two (p<0.0001,
no better fits after 104 permutations) and compositional comparison also showed similar profiles
(Supplementary Figure 4-1).
The longitudinal behavior of fungal communities was explored in detail using the ITS
amplicon, which revealed strong effects of both antibiotic treatment and housing history of the
animals (Figure 4-7; the full set of time points, with each animal shown individually is in
Supplementary Figure 4 A-I). In the control animals (five mice in each of two cages), although
the composition of the bacterial community remained relatively stable, the fungal community
changed dramatically. For four samples taken over the first eight days, most of the ten mice in
the two cages showed colonization by diverse fungal lineages, and no lineage predominated. By
day 15, however, the situation had changed radically, with both cages dominated by a phylotype
annotated as Wickerhamomyces. This changed by day 22, with cage 1 dominated by
Debaryomyces, and the second cage showing more diverse colonization, where Debaryomyces
was present but not predominant. The outgrowth of Debaryomyces in cage 1 correlated with the
increase in abundance of total DNA in the 18S QPCR analysis in the control animals at day 22
(Figure 4-3), which also occurred only in cage 1. By day 76 the controls had changed again. At
this time both cages were dominated by Eurotiales, though the abundance was greater in cage 1
than cage 2. These findings document radical changes in murine gut fungi 1) in a single mouse
facility 2) for mice on a homogeneous diet, 3) in the absence of any intervention, and 4) differing
between cages.
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For the antibiotic treated animals, the communities were diverse prior to initiation of
treatment, then under treatment showed cage-specific patterns of divergence. By day 2,
Clavispora and Cyberlindnera were predominant in both cages in the ABXContinuous group and
cage 1 in the ABXShortTerm group. In cage 2 in the short term group the mice were more
heterogenous, with Candida, Cyberlindnera, and Pichia dominating in different mice. By day 6
this had changed, with Cyberlinderna dominating in three cages (both ABXContinuous and
ABXShortTerm cage 1), and Candida dominating in all mice in ABXShortTerm cage 2. This
pattern persisted at day 15, but by day 22 one ABXContinuous cage was dominated by Candida,
and by day 76 Candida was the only fungus detectable in both ABXContinuous cages. For the
ABXShortTerm mice, Sporopachydermis dominated in cage 1 and Candida in cage 2 on day 22,
then the fungal populations returned to a more diverse mixture by day 76, but Candida was
relatively abundant in most of the short term treated mice at the last time point studied. Thus
these data emphasize the heterogeneity of the community responses in individual cages, but also
the robust persistence of the Candida community. A few samples were also analyzed with the
18S rRNA gene amplicon and generally yielded similar results (Supplementary Figure 4-1). An
analysis of mouse chow DNA using the ITS amplicon showed no obvious relationship to the
major lineages detected in pellets (Supplementary Figure 4-3B).
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Figure 4-7. Longitudinal analysis of fungal lineages inferred from ITS rRNA gene
sequencing. Fungal lineages detected are summarized in heat map format. Data for four
days are shown (days 1, 15, 22, and 76). Each column indicates a single mouse. The groups
tested are indicated at the top of the columns. The ten mice in each of the three treatment
groups were each housed in two cages of five each. The distribution of mice in cages is
indicated at the bottom of the columns. The day of treatment is indicated at the top. The
color code to the right indicates the proportions.
Initially an average of 30.7 (SD=9.9) phylotypes were detected in the ITS data per animal
(Figure 4-8), but these numbers fell to 5.2 (SD=2.9) per animal during antibiotic treatment as the
Candida overgrew the community. Upon cessation of antibiotic treatment the number of
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phylotypes returned to their former levels (31.1, SD=8.0). Thus the fungal community returned
to its original richness (p=0.673, Mann-Whintey U), but despite this, the contribution of Candida
was higher than before treatment.

Figure 4-8. Abundance analysis of observed fungal lineages. Each sequence set was
rarefied to 200 sequences per sample, and the number of different OTUs assessed. Means
are indicated by points, error bars indicate the range observed. The groups studied are
indicated by the key at the right.
Community comparisons using Unifrac
To compare community structures over the course of antibiotic treatment, the 454 data
for the 16S and ITS tags were analyzed using weighted[62] and unweighted[63] Unifrac
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(Supplementary Figure 4-5). We tested for differenced in community composition between the
control group and the treatment groups at each time point by comparing distances within the
control group to distances between control and treatment groups. Significance was determined
using the Mann-Whitney test.
The ABXShortTerm and ABXContinuous groups were not significantly different from
the Control group before antibiotic treatment for either the bacterial or fungal communities
(Supplementary Figure 4-5). After one day of treatment, both groups were significantly different
from the Control in both weighted and unweighted Unifrac and remained distinct throughout the
antibiotic treatment (Supplementary Figure 4-5). One week after the ShortTermABX group
stopped receiving antibiotics, both the bacterial and fungal communities remained significantly
different from the other two (Supplementary Figure 4-5). On day 76, 61 days after antibiotic
cessation, differences between the bacterial communities were slight but still achieved
significance in the weighted and unweighted analysis, and some but not all comparisons were
significant for the ITS analysis. Thus by the last time point the communities had approached but
not completely returned to their pre-treatment states (p<0.005).

4.5 Discussion
We report a study of the response of bacterial and fungal communities in the mouse gut
to antibiotic treatment. Animals were tracked over 76 days, and sampled densely over this
period. Use of both QPCR to assess total abundance and 454/Roche sequencing to quantify
community structure provided a detailed picture of the effects of antibiotic treatment and
subsequent recovery on the gut microbiome.
The bacterial communities initially were dominated by Bacteriodetes and
Lachnospiraceae, then changed quickly during the antibiotic treatment, reaching a stable state by
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day two. At this time, the number of inferred organisms had dropped >3 orders of magnitude, to
the point that the 16S rRNA gene sequences were mostly transients from food, documenting near
complete clearance of bacteria from the gut. Upon cessation of antibiotic treatment, the bacteria
returned to nearly their original state, though perturbations remained. The control animals
remained relatively stable over the time course, dominated by Bacteriodetes and Lachnospiraceae
throughout.
Fungal communities changed radically over the time course studied, in association with
the caging history of the mice. Even the untreated Control group showed waves of succession
that differed in each cage. Cage 1 was first heterogenous, then dominated by Wickerhamomyces,
then Debaryomyces, then Eurotiales. Cage 2 was heterogenous through the first six days, then
dominated by Wickerhamomyces, then again heterogeneous. These data document a quite
surprising degree of fungal variation in healthy laboratory mice.
Previous studies have shown that colonization by specific bacteria in mice can strongly
influence the outcome of immunological assays [64]. Given the recently reported importance of
fungi in mouse models of IBD [36], our data suggest that researchers will need to take care to
monitor and control fungal populations to obtain meaningful data. The mice in this study were
housed on a conventional SPF environment. It would be useful to compare housing in a barrier
facility where food, water, and bedding have all been sterilized. Colitis phenotypes in
genetically-determined mouse models are known to vary in different facilities, suggesting that it
will be useful to assess the role of variability in fungal colonization.
In the presence of antibiotics, the fungal community showed several waves of succession,
which again differed between cages. Depending on the cage and time point, the communities
could be heterogeneous, or dominated by Clavispora, Cyberlindnera, Sporopachydermia or
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Candida. In cases where communities in a cage were dominated by a single fungal lineage, this
was true of all mice in the cage at that time point. One likely explanation is that coprophagia
resulted in all mice in a single cage acquiring the same fungal colonists. Some of these fungal
lineages were seen sporadically in contamination controls (Supplementary Figure 4-6),
suggesting that gut fungi may have been acquired episodically from the environment.
Candida was a particularly robust colonist in the presence of antibiotics. By day 76, all the
ABXContinuous mice were colonized at a high level exclusively by Candida. Further supporting
the robustness of Candida, results from cage two in the ABXShortTerm group by chance
provides a competition experiment. Of the five mice analyzed on day two, two were colonized
with Candida, one with Cyberlindnera, one with Pichia, and one with both Candida and
Cyberlindnera (Supplementary Figure 4-4, part C). Coprophagia would presumably allow the
three species to compete for colonization opportunities. By day six, all mice were colonized with
Candida, and this persisted through the cessation of antibiotic treatment by day 22. At the end of
the experiment on day 76, Candida was still more abundant in the ABXShortTerm group than
prior to treatment, all emphasizing that Candida was favored by the antibiotic treatment and
persisted subsequently.
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Supplementary Information

Supplementary Figure 4-1. Figure S1. Comparison of microeukaryote lineages specified by
the ITS and 18S amplicons. A) Heat maps comparing selected samples analyzed using both
the 18S and ITS amplicons. Each column shows the average for mice in the group and at
the time point indicated rarefied to 200 reads per individual. The color code to the right
indicates the scale. B) Procrustes analysis comparing results for the 18S and ITS analysis.
Data from the 18S and ITS amplicons for each mouse are shown by balls connected by a
line.
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Supplementary Figure 4-2. Heat maps showing the composition of bacterial communities
inferred from 16S sequence data for each time point (A-I), with each mouse shown
individually. The scale of relative proportions is shown on the right.
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Supplementary Figure 4-3. 16S and ITS sequences recovered from five samples of mouse
chow. A) Sequences from the 16S analysis. B) Sequences from the ITS analysis. The scale
of relative proportions is shown on the far right.
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Supplementary Figure 4-4. Heat maps showing the composition of fungal communities
inferred from ITS sequence data for each time point (A-G), with each mouse shown
individually. The scale of relative proportions is shown on the right.
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Supplementary Figure 4-5. PCoA analysis distances measures for bacterial (16S sequence
data) and fungal (ITS sequence data) communities. Distances matrices were calculated
using weighted or unweighted UniFrac, then the pairwise distances between a treatment
group and the control group compared to the distances within the control group on that
day. Asterisks above each box and whisker plot indicate whether the comparison was
significantly different.
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Supplementary Figure 4-6. Comparison of contamination controls to experimental samples
for the 16S A) and ITS B) amplicons. “Extraction control” indicates sequences derived
from blank purifications using DNA-free water. Each column showing mouse data is an
average over all reads at that time point.
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Amount

ratio (no
Abx/Abx)

Average DNA yield no Abx (ng)

6.10E+02

4.68E+00

Average DNA yield day 15 Abx (ng)

1.30E+02

Average bacterial genomes no Abx

1.24E+07

Average bacterial genomes day 15 Abx

1.35E+02

Average fungal genomes no Abx per pellet

5.95E+03

Average fungal gneomes day 15 Abx per pellet

2.35E+05

Average DNA yield no Abx (ng)

6.10E+02

Average DNA yield day 76 Abx (ng)

1.08E+02

Average bacterial genomes no Abx per pellet

1.24E+07

Average bacterial genomes day 76 Abx per pellet

3.82E+02

Average fungal genomes no Abx

5.95E+03

Average fungal gneomes day 76 Abx

1.00E+05

9.13E+04

2.53E-02

5.65E+00

3.24E+04

5.95E-02

Supplementary Table 4-3. Ratios for DNA yields, average
bacterial genomes, and average fungal genomes for selected
comparisons between groups.
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CHAPTER 5: Conclusions and Future Directions
In this dissertation I present novel methods for characterizing understudied clades of the
gut microbiome and an application that highlights the utility and necessity for such methods.
Species in the gut interact across domains, forming a single community [1]. Bacteria, archaea,
and eukarya all contain different metabolic capabilities, which can be strung together to form
metabolic pathways with different steps taking place in different species. Nevertheless, most
studies have focused on studying the bacterial community in isolation, which provides a useful
yet incomplete picture of microbiome dynamics. Subsequently, we developed methods to
characterize the archaeal and eukaryotic components and explore the selective effects of
antibiotic treatment across bacterial and eukaryotic gut communities.
In Chapter 2, I present a sample-to-analysis pipeline for characterizing microeukaryotic
communities within the gut microbiome. Development of a targeted assay to study
microeukaryotes is important, because there is evidence that microeukaryotes, and particularly
fungi, are underrepresented in metagenomic sequencing assemblies [2]. This method was
particularly challenging to develop because of the homology between the host genome and the
genomes of the commensal microeukaryotes. We tested several primers, looking at breadth and
specificity. Ultimately, 18S rDNA and ITS primers proved to capture their targeted communities
accurately. The 18S amplicon detected a wide range of fungi and protozoa. The ITS amplicon
only detected fungi but provided superior differentiation between closely related species. We also
tested several DNA extraction methods, and determined that harsher lysis methods improve
fungal DNA yield, as has been corroborated by others [3]. In addition to wet side methods, I also
developed the BROCC program to automate taxonomic attribution of microeukaryotic sequences
through voting on high quality, classified BLAST hits. Ultimately, this work provides a
framework for future studies of the eukaryotic components of the gut microbiome.
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While this study made great strides in understanding the fungal and protozoan gut
community, community characterization was hampered by poorly curated databases. Specifically,
many OTUs matched database sequences with high identity, but these database sequences were
classified only to the phylum or kingdom level (i.e. ‘uncultured fungi’). Many of these sequences
likely come from understudied microeukaryotic lineages. Recently, several projects have
produced useful databases characterizing the genomes of eukaryotic species of interest to
humanity [4,5,6]. The creation of a large amplicon specific database with good coverage of all
known lineages, particularly of the fungi, for the ITS gene would greatly aid future studies.
In Chapter 3, I present a wet lab workup protocol to characterize archaeal communities in
the gut microbiome. This method was developed through testing different primer pairs,
thermocycling conditions, and extraction techniques. Through limited Sanger sequencing I found
Methanobrevibactor in human and macaque samples and Methanobrevibactor, Methanococcus,
and Thermogymnomonas in murine samples. Previously, archaeal communities were
characterized indirectly through qPCR [7] or metagenomic shotgun sequencing [8]. These
techniques are not ideal for community characterization because qPCR does not easily
differentiate between different species, and metagenomic sequencing is vulnerable to coverage
related assembly problems [9], which can be exacerbated in rare community members such as
archaea. The method I developed enables direct determination of the identity of different
members of an archaeal microbiome community.
In this study, we detected the acidophilic genus Thermogymnomonas in stool. As was
observed in both Chapters 2 and 4, genomic DNA is capable of surviving a trip through the
digestive tract and being detected in stool. This is a key observation, because many members of
the Thermogymnomonas genus and its class Thermoplasmata live between pH 0 and 4 [10,11,12],
and the type species for the genus Thermogymnomonas acidicola grow optimally at pH 3[13].
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Yet, species classified as Thermogymnomonas were detected in stool samples which are generally
thought to be a good representation of the lower GI tract, even though the colon has a pH close to
7 [14,15]. Subsequently, it is important to determine whether the Thermogymnomonas detected
was actually inhabiting the colon through some evolutionary adjustments that allow it to survive
at higher pH levels, or was inhabiting the stomach, with an approximate pH between 1 and 5
depending on the location and presence of food [16], which would be much more habitable for an
acidophile. Currently, the only microbe known to commonly inhabit the stomach is Helicobacter
pylori [17], which can cause ulcers and other gastric disease or live asymptomatically [18].
Discovery and characterization of additional stomach microbiome inhabitants could provide more
information about the causes of gastric disease and aid its treatment.
In Chapter 4, I analyze the longitudinal effects of heavy antibiotic use during and after
treatment in a mouse model using a cocktail of ampicillin, neomycin, vancomycin, and
metronidazole. We found that this mixture of antibiotics effectively suppresses the commensal
bacterial community to the point where the only detectable species is Lactococcus lactis, which is
likely derived from food manufacturing. Eight weeks after antibiotic treatment was stopped,
many bacterial groups that were common before treatment returned, and cell counts returned to
their previous levels. However, species composition and diversity were significantly different
from untreated controls, indicating potential long term perturbation of the bacterial community.
Under antibiotic treatment, we also observed three species of Saccharomycetales yeasts grow out
in succession, increasing the fungal genome count by one to two orders of magnitude. After
cessation of antibiotic treatment, fungal counts returned to normal levels within one week and to
normal diversity and community composition 8 weeks later compared to untreated controls.
Unexpectedly we also observed that fungal communities in the controls rapidly change
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composition without intervention, indicating the fungal gut community is less stable than
bacterial gut community.
The effects of heavy antibiotic use are not well characterized in the human gut. I would
expect different effects from our findings in Chapter 4 because unlike laboratory mice, most
humans have had prior antibiotic exposure, and studies have indicated that the human gut is a
reservoir for antibiotic resistance genes [19]. Heavy antibiotic use may have a less potent effect
on humans than naïve mice. Also, as we saw in Chapter 2, many of the fungal sequences in
human studies are suspected to be derived food sources, and it is unclear if these cells are alive
and viable. Suppression of the bacterial community should cause a fungal outgrowth, but it is
unknown if Candida albicans, which has been documented to grow out with antibiotic treatment,
would grow out alone or with other fungi because other yeasts have been documented to grow out
as well [20]. It would be informative to see if any species that are thought to be food derived
grow out as well. Species like Saccharomyces cerevisiae have been documented to cause
infection in rare cases [21], but it is unknown if it is a dynamic member of the gut community.
Furthermore, the longitudinal effects of narrower spectrum and single antibiotic
treatments on the gut microbiota still need to be studied. Many antibiotic regimens prescribed
today consist of a single antibiotic used for a short time period to resolve acute bacterial infection
[22]. However, long term side effects have been associated with antibiotic use, such as obesity
[23]. Understanding the potential long term effects of more typical treatments on the gut
microbiome may aid clinicians when prescribing antibiotics.
This dissertation presents a framework for characterizing understudied clades of the
microbiome and direct experimentation through use of antibiotics. The methods developed here
enable researchers to characterize archaea, fungi, and protozoans in microbiome samples. The
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antibiotic study not only describes the effects of heavy antibiotic treatment on bacterial and
fungal communities, but it provides a framework for analyzing future antibiotic microbiome
studies, and highlights the quirks of using such a model, such as detection of bacterial DNA in
food and observing a succession of fungal species dominate the gut, thereby enabling researchers
to avoid potential pitfalls. This research can aid a wide variety of future studies of microbial and
microbiome communities within the fields of microbiology, immunology, and even ecology.
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APPENDIX
Appendix 1- Plasmids Developed During Thesis Project

Acession
Number

Gene

Species

1143
1142
1145

18S-Near Full
18S-Near Full
ITS1, 5.S, and ITS2

1146

16S -Near Full

1147
1144

16S -Near Full
16S-Partial

Candida
Candida
Candida
Methanococcus
maripaludis
Sulfolobus solfataricus
Methanobrevibactor
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Plasmid
Backbone
Topo4
Topo4
Topo4
Topo4
Topo4
Topo4

